[
  {
    "title": "A Look at Pharma ETFs Post Q1 Earnings",
    "published": 1715095800,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 43.97999954223633,
      "2024-05-07T14:30:00+00:00": 44.064998626708984,
      "2024-05-07T15:30:00+00:00": 44.029998779296875,
      "2024-05-07T16:30:00+00:00": 44.1781005859375,
      "2024-05-07T17:30:00+00:00": 44.099998474121094,
      "2024-05-07T18:30:00+00:00": 43.93000030517578,
      "2024-05-07T19:30:00+00:00": 43.900001525878906
    },
    "sentiment": 0.9325221180915833
  },
  {
    "title": "Bristol Myers Squibb to Participate in Upcoming Investor Conferences",
    "published": 1715079540,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 43.97999954223633,
      "2024-05-07T14:30:00+00:00": 44.064998626708984,
      "2024-05-07T15:30:00+00:00": 44.029998779296875,
      "2024-05-07T16:30:00+00:00": 44.1781005859375,
      "2024-05-07T17:30:00+00:00": 44.099998474121094,
      "2024-05-07T18:30:00+00:00": 43.93000030517578,
      "2024-05-07T19:30:00+00:00": 43.900001525878906
    },
    "sentiment": 0.89532470703125
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (LYRA), Bristol-Myers Squibb (BMY) and Axsome Therapeutics (AXSM)",
    "published": 1715055840,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 43.97999954223633,
      "2024-05-07T14:30:00+00:00": 44.064998626708984,
      "2024-05-07T15:30:00+00:00": 44.029998779296875,
      "2024-05-07T16:30:00+00:00": 44.1781005859375,
      "2024-05-07T17:30:00+00:00": 44.099998474121094,
      "2024-05-07T18:30:00+00:00": 43.93000030517578,
      "2024-05-07T19:30:00+00:00": 43.900001525878906
    },
    "sentiment": 0.9137399792671204
  },
  {
    "title": "FDA accepts Bristol Myers application for injected Opdivo",
    "published": 1714994100,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.5047883987426758
  },
  {
    "title": "U.S. Food and Drug Administration Accepts Bristol Myers Squibb\u2019s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)",
    "published": 1714993140,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.8978764414787292
  },
  {
    "title": "Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation",
    "published": 1714981896,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.927141010761261
  },
  {
    "title": "Bristol Myers' application for Opdivo plus Yervoy validated by EMA",
    "published": 1714975500,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 44.15999984741211,
      "2024-05-06T14:30:00+00:00": 44.22999954223633,
      "2024-05-06T15:30:00+00:00": 44.005001068115234,
      "2024-05-06T16:30:00+00:00": 44.0088996887207,
      "2024-05-06T17:30:00+00:00": 43.99020004272461,
      "2024-05-06T18:30:00+00:00": 44.040000915527344,
      "2024-05-06T19:30:00+00:00": 43.80690002441406
    },
    "sentiment": 0.9060776233673096
  },
  {
    "title": "Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago",
    "published": 1714820480,
    "day_prices": {},
    "sentiment": 0.9702085256576538
  },
  {
    "title": "Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?",
    "published": 1714743000,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 43.959999084472656,
      "2024-05-03T14:30:00+00:00": 44.04999923706055,
      "2024-05-03T15:30:00+00:00": 43.91999816894531,
      "2024-05-03T16:30:00+00:00": 43.94499969482422,
      "2024-05-03T17:30:00+00:00": 43.790000915527344,
      "2024-05-03T18:30:00+00:00": 43.849998474121094,
      "2024-05-03T19:30:00+00:00": 43.849998474121094
    },
    "sentiment": 0.915772020816803
  },
  {
    "title": "If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today",
    "published": 1714734900,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 43.959999084472656,
      "2024-05-03T14:30:00+00:00": 44.04999923706055,
      "2024-05-03T15:30:00+00:00": 43.91999816894531,
      "2024-05-03T16:30:00+00:00": 43.94499969482422,
      "2024-05-03T17:30:00+00:00": 43.790000915527344,
      "2024-05-03T18:30:00+00:00": 43.849998474121094,
      "2024-05-03T19:30:00+00:00": 43.849998474121094
    },
    "sentiment": 0.9371642470359802
  },
  {
    "title": "The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine",
    "published": 1714727280,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 43.959999084472656,
      "2024-05-03T14:30:00+00:00": 44.04999923706055,
      "2024-05-03T15:30:00+00:00": 43.91999816894531,
      "2024-05-03T16:30:00+00:00": 43.94499969482422,
      "2024-05-03T17:30:00+00:00": 43.790000915527344,
      "2024-05-03T18:30:00+00:00": 43.849998474121094,
      "2024-05-03T19:30:00+00:00": 43.849998474121094
    },
    "sentiment": 0.94817054271698
  },
  {
    "title": "Bristol-Myers Squibb: A Lost Decade?",
    "published": 1714683666,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 44.36000061035156,
      "2024-05-02T14:30:00+00:00": 43.7599983215332,
      "2024-05-02T15:30:00+00:00": 43.92499923706055,
      "2024-05-02T16:30:00+00:00": 44.0,
      "2024-05-02T17:30:00+00:00": 43.939998626708984,
      "2024-05-02T18:30:00+00:00": 43.83000183105469,
      "2024-05-02T19:30:00+00:00": 43.790000915527344
    },
    "sentiment": 0.5306175947189331
  },
  {
    "title": "Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More",
    "published": 1714658520,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 44.36000061035156,
      "2024-05-02T14:30:00+00:00": 43.7599983215332,
      "2024-05-02T15:30:00+00:00": 43.92499923706055,
      "2024-05-02T16:30:00+00:00": 44.0,
      "2024-05-02T17:30:00+00:00": 43.939998626708984,
      "2024-05-02T18:30:00+00:00": 43.83000183105469,
      "2024-05-02T19:30:00+00:00": 43.790000915527344
    },
    "sentiment": 0.6145809292793274
  },
  {
    "title": "3 Blue-Chip Bargains Trading At 52-Week Lows",
    "published": 1714633200,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 44.36000061035156,
      "2024-05-02T14:30:00+00:00": 43.7599983215332,
      "2024-05-02T15:30:00+00:00": 43.92499923706055,
      "2024-05-02T16:30:00+00:00": 44.0,
      "2024-05-02T17:30:00+00:00": 43.939998626708984,
      "2024-05-02T18:30:00+00:00": 43.83000183105469,
      "2024-05-02T19:30:00+00:00": 43.790000915527344
    },
    "sentiment": 0.9381420016288757
  },
  {
    "title": "Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration",
    "published": 1714564800,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 43.970001220703125,
      "2024-05-01T14:30:00+00:00": 44.119998931884766,
      "2024-05-01T15:30:00+00:00": 44.165000915527344,
      "2024-05-01T16:30:00+00:00": 44.189998626708984,
      "2024-05-01T17:30:00+00:00": 44.1349983215332,
      "2024-05-01T18:30:00+00:00": 44.01499938964844,
      "2024-05-01T19:30:00+00:00": 44.290000915527344
    },
    "sentiment": 0.8614452481269836
  },
  {
    "title": "Editas Medicine, Bristol Myers extend alpha-beta T cell collaboration",
    "published": 1714547940,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 43.970001220703125,
      "2024-05-01T14:30:00+00:00": 44.119998931884766,
      "2024-05-01T15:30:00+00:00": 44.165000915527344,
      "2024-05-01T16:30:00+00:00": 44.189998626708984,
      "2024-05-01T17:30:00+00:00": 44.1349983215332,
      "2024-05-01T18:30:00+00:00": 44.01499938964844,
      "2024-05-01T19:30:00+00:00": 44.290000915527344
    },
    "sentiment": 0.8017661571502686
  },
  {
    "title": "Hold Rating on Bristol-Myers Squibb Amid Earnings Uncertainty and Strategic Investments",
    "published": 1714541880,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 43.970001220703125,
      "2024-05-01T14:30:00+00:00": 44.119998931884766,
      "2024-05-01T15:30:00+00:00": 44.165000915527344,
      "2024-05-01T16:30:00+00:00": 44.189998626708984,
      "2024-05-01T17:30:00+00:00": 44.1349983215332,
      "2024-05-01T18:30:00+00:00": 44.01499938964844,
      "2024-05-01T19:30:00+00:00": 44.290000915527344
    },
    "sentiment": 0.8670029640197754
  },
  {
    "title": "Bristol Myers Squibb\u2019s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma",
    "published": 1715806685,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.8672182559967041
  },
  {
    "title": "US FDA approves expanded use of Bristol's cancer cell therapy",
    "published": 1715792156,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.7745218276977539
  },
  {
    "title": "Bristol Myers' Breyanzi CAR-T therapy approved by FDA in follicular lymphoma",
    "published": 1715760000,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.8509728908538818
  },
  {
    "title": "Bristol Myers' Breyanzi gains additional indication for follicular lymphoma",
    "published": 1715748120,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 45.0,
      "2024-05-15T14:30:00+00:00": 44.790000915527344,
      "2024-05-15T15:30:00+00:00": 44.79840087890625,
      "2024-05-15T16:30:00+00:00": 44.755001068115234,
      "2024-05-15T17:30:00+00:00": 44.72999954223633,
      "2024-05-15T18:30:00+00:00": 44.6150016784668,
      "2024-05-15T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.9256910085678101
  },
  {
    "title": "Dividend Capture Captains: The 3 Best Blue-Chip Stocks for Tactical Traders",
    "published": 1715683560,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 45.380001068115234,
      "2024-05-14T14:30:00+00:00": 44.8849983215332,
      "2024-05-14T15:30:00+00:00": 44.7400016784668,
      "2024-05-14T16:30:00+00:00": 44.64500045776367,
      "2024-05-14T17:30:00+00:00": 44.56999969482422,
      "2024-05-14T18:30:00+00:00": 44.61000061035156,
      "2024-05-14T19:30:00+00:00": 44.8849983215332
    },
    "sentiment": 0.8380469679832458
  },
  {
    "title": "Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug",
    "published": 1715662879,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 45.380001068115234,
      "2024-05-14T14:30:00+00:00": 44.8849983215332,
      "2024-05-14T15:30:00+00:00": 44.7400016784668,
      "2024-05-14T16:30:00+00:00": 44.64500045776367,
      "2024-05-14T17:30:00+00:00": 44.56999969482422,
      "2024-05-14T18:30:00+00:00": 44.61000061035156,
      "2024-05-14T19:30:00+00:00": 44.8849983215332
    },
    "sentiment": 0.5977020263671875
  },
  {
    "title": "One stock is dragging down the S&P 500's earnings growth",
    "published": 1715618473,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9579587578773499
  },
  {
    "title": "Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study",
    "published": 1715613360,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9585000872612
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)",
    "published": 1715610188,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9365403652191162
  },
  {
    "title": "Merck discontinues testing of experimental skin cancer combo therapy",
    "published": 1715583840,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 44.880001068115234,
      "2024-05-13T14:30:00+00:00": 45.20000076293945,
      "2024-05-13T15:30:00+00:00": 45.13999938964844,
      "2024-05-13T16:30:00+00:00": 45.125,
      "2024-05-13T17:30:00+00:00": 45.064998626708984,
      "2024-05-13T18:30:00+00:00": 45.084999084472656,
      "2024-05-13T19:30:00+00:00": 44.92499923706055
    },
    "sentiment": 0.9100384712219238
  },
  {
    "title": "Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip",
    "published": 1715503500,
    "day_prices": {},
    "sentiment": 0.8015245199203491
  },
  {
    "title": "Organon Graduates From Spinoff\u00a0Skepticism, With A Yield Above 5%",
    "published": 1715410713,
    "day_prices": {},
    "sentiment": 0.7050560712814331
  },
  {
    "title": "Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial",
    "published": 1715373000,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 44.75,
      "2024-05-10T14:30:00+00:00": 44.82500076293945,
      "2024-05-10T15:30:00+00:00": 44.685001373291016,
      "2024-05-10T16:30:00+00:00": 44.709999084472656,
      "2024-05-10T17:30:00+00:00": 44.790000915527344,
      "2024-05-10T18:30:00+00:00": 44.69430160522461,
      "2024-05-10T19:30:00+00:00": 44.83000183105469
    },
    "sentiment": 0.9249863624572754
  },
  {
    "title": "Success Rate as High as 90% for AI-Discovered Drugs",
    "published": 1715317500,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 44.75,
      "2024-05-10T14:30:00+00:00": 44.82500076293945,
      "2024-05-10T15:30:00+00:00": 44.685001373291016,
      "2024-05-10T16:30:00+00:00": 44.709999084472656,
      "2024-05-10T17:30:00+00:00": 44.790000915527344,
      "2024-05-10T18:30:00+00:00": 44.69430160522461,
      "2024-05-10T19:30:00+00:00": 44.83000183105469
    },
    "sentiment": 0.8889439702033997
  },
  {
    "title": "Bristol Myers announces CheckMate -73L trial did not meet primary endpoint",
    "published": 1715311920,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 44.75,
      "2024-05-10T14:30:00+00:00": 44.82500076293945,
      "2024-05-10T15:30:00+00:00": 44.685001373291016,
      "2024-05-10T16:30:00+00:00": 44.709999084472656,
      "2024-05-10T17:30:00+00:00": 44.790000915527344,
      "2024-05-10T18:30:00+00:00": 44.69430160522461,
      "2024-05-10T19:30:00+00:00": 44.83000183105469
    },
    "sentiment": 0.8478593230247498
  },
  {
    "title": "Moat Stocks React To Inflation And Slowing Growth",
    "published": 1715253000,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 43.560001373291016,
      "2024-05-09T14:30:00+00:00": 43.900001525878906,
      "2024-05-09T15:30:00+00:00": 43.880001068115234,
      "2024-05-09T16:30:00+00:00": 43.86000061035156,
      "2024-05-09T17:30:00+00:00": 44.064998626708984,
      "2024-05-09T18:30:00+00:00": 44.28499984741211,
      "2024-05-09T19:30:00+00:00": 44.494998931884766
    },
    "sentiment": 0.42709460854530334
  },
  {
    "title": "Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution",
    "published": 1715166012,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 44.0,
      "2024-05-08T14:30:00+00:00": 43.810001373291016,
      "2024-05-08T15:30:00+00:00": 43.73500061035156,
      "2024-05-08T16:30:00+00:00": 43.709999084472656,
      "2024-05-08T17:30:00+00:00": 43.58000183105469,
      "2024-05-08T18:30:00+00:00": 43.73500061035156,
      "2024-05-08T19:30:00+00:00": 43.654998779296875
    },
    "sentiment": 0.6394791603088379
  },
  {
    "title": "Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?",
    "published": 1716469219,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.7013425827026367
  },
  {
    "title": "Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus",
    "published": 1716467812,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.8098769187927246
  },
  {
    "title": "Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting",
    "published": 1716461940,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9381774663925171
  },
  {
    "title": "Bristol-Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity",
    "published": 1716454740,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9280712008476257
  },
  {
    "title": "SMALL-CAP WINNERS & LOSERS: Capital & Regional gets takeover offer",
    "published": 1716440940,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9419151544570923
  },
  {
    "title": "LONDON MARKET OPEN: National Grid drags FTSE 100 lower",
    "published": 1716437040,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.9537860155105591
  },
  {
    "title": "Bloomsbury Publishing Announces New Chairman",
    "published": 1716430080,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 41.91999816894531,
      "2024-05-23T14:30:00+00:00": 41.79249954223633,
      "2024-05-23T15:30:00+00:00": 41.73500061035156,
      "2024-05-23T16:30:00+00:00": 41.875,
      "2024-05-23T17:30:00+00:00": 41.79999923706055,
      "2024-05-23T18:30:00+00:00": 41.63669967651367,
      "2024-05-23T19:30:00+00:00": 41.65999984741211
    },
    "sentiment": 0.8524619936943054
  },
  {
    "title": "Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M",
    "published": 1716405912,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.9097902178764343
  },
  {
    "title": "Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo",
    "published": 1716398040,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8350327610969543
  },
  {
    "title": "Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million",
    "published": 1716393962,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8466559648513794
  },
  {
    "title": "Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines",
    "published": 1716379063,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.7279292941093445
  },
  {
    "title": "Bristol Myers: 10-year strategy for poor countries",
    "published": 1716363416,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8093820810317993
  },
  {
    "title": "Bristol Myers announces strategy to reach low- and middle-income countries",
    "published": 1716357720,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.5341288447380066
  },
  {
    "title": "Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit",
    "published": 1716352124,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.9458606243133545
  },
  {
    "title": "Bristol-Myers Squibb snaps six days of losses, trades in the green",
    "published": 1716348360,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.8081240653991699
  },
  {
    "title": "Bristol Myers, Sanofi liability in Hawaii Plavix litigation tops $900M",
    "published": 1716345600,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 42.220001220703125,
      "2024-05-22T14:30:00+00:00": 42.494998931884766,
      "2024-05-22T15:30:00+00:00": 42.58000183105469,
      "2024-05-22T16:30:00+00:00": 42.6150016784668,
      "2024-05-22T17:30:00+00:00": 42.690101623535156,
      "2024-05-22T18:30:00+00:00": 42.459999084472656,
      "2024-05-22T19:30:00+00:00": 42.415000915527344
    },
    "sentiment": 0.7823261022567749
  },
  {
    "title": "1 Stock I Wouldn't Touch With a 10-Foot Pole",
    "published": 1716293700,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9282525181770325
  },
  {
    "title": "Bristol Myers: national schizophrenia campaign",
    "published": 1716289962,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9165869355201721
  },
  {
    "title": "Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity",
    "published": 1716288480,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.8404976725578308
  },
  {
    "title": "Interesting BMY Put And Call Options For March 2025",
    "published": 1716284160,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9389216899871826
  },
  {
    "title": "Bristol-Myers says FDA has revised decision date on injected Opdivo",
    "published": 1716273120,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.5019626617431641
  },
  {
    "title": "Bristol Myers announces updated action date by FDA for nivolumab",
    "published": 1716271320,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 43.13999938964844,
      "2024-05-21T14:30:00+00:00": 42.858001708984375,
      "2024-05-21T15:30:00+00:00": 42.82500076293945,
      "2024-05-21T16:30:00+00:00": 42.564998626708984,
      "2024-05-21T17:30:00+00:00": 42.54499816894531,
      "2024-05-21T18:30:00+00:00": 42.564998626708984,
      "2024-05-21T19:30:00+00:00": 42.375
    },
    "sentiment": 0.9115890860557556
  },
  {
    "title": "November 15th Options Now Available For Bristol Myers Squibb (BMY)",
    "published": 1716198180,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 44.0,
      "2024-05-20T14:30:00+00:00": 43.948699951171875,
      "2024-05-20T15:30:00+00:00": 43.8650016784668,
      "2024-05-20T16:30:00+00:00": 43.724998474121094,
      "2024-05-20T17:30:00+00:00": 43.69499969482422,
      "2024-05-20T18:30:00+00:00": 43.654998779296875,
      "2024-05-20T19:30:00+00:00": 43.525001525878906
    },
    "sentiment": 0.9414032697677612
  },
  {
    "title": "Novo Nordisk, J&J lead R&D rankings in big pharma: report",
    "published": 1715997240,
    "day_prices": {},
    "sentiment": 0.8400076031684875
  },
  {
    "title": "May's 5 Dividend Growth Stocks With 5.49%+ Yields",
    "published": 1715954969,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 44.29999923706055,
      "2024-05-17T14:30:00+00:00": 43.83000183105469,
      "2024-05-17T15:30:00+00:00": 43.72999954223633,
      "2024-05-17T16:30:00+00:00": 43.810001373291016,
      "2024-05-17T17:30:00+00:00": 44.1349983215332,
      "2024-05-17T18:30:00+00:00": 44.14500045776367,
      "2024-05-17T19:30:00+00:00": 44.13050079345703
    },
    "sentiment": 0.48929792642593384
  },
  {
    "title": "The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers",
    "published": 1715947440,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 44.29999923706055,
      "2024-05-17T14:30:00+00:00": 43.83000183105469,
      "2024-05-17T15:30:00+00:00": 43.72999954223633,
      "2024-05-17T16:30:00+00:00": 43.810001373291016,
      "2024-05-17T17:30:00+00:00": 44.1349983215332,
      "2024-05-17T18:30:00+00:00": 44.14500045776367,
      "2024-05-17T19:30:00+00:00": 44.13050079345703
    },
    "sentiment": 0.944409966468811
  },
  {
    "title": "BMS reports four-year data from psoriasis treatment extension trial",
    "published": 1715935324,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 44.29999923706055,
      "2024-05-17T14:30:00+00:00": 43.83000183105469,
      "2024-05-17T15:30:00+00:00": 43.72999954223633,
      "2024-05-17T16:30:00+00:00": 43.810001373291016,
      "2024-05-17T17:30:00+00:00": 44.1349983215332,
      "2024-05-17T18:30:00+00:00": 44.14500045776367,
      "2024-05-17T19:30:00+00:00": 44.13050079345703
    },
    "sentiment": 0.7566370368003845
  },
  {
    "title": "Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY",
    "published": 1715877960,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.6718593239784241
  },
  {
    "title": "Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion",
    "published": 1715862900,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.661754846572876
  },
  {
    "title": "FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated Follicular Lymphoma",
    "published": 1715857200,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.8431336283683777
  },
  {
    "title": "Bristol Myers reports new four-year Sotyktu data",
    "published": 1715851740,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.8657287955284119
  },
  {
    "title": "Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma",
    "published": 1715842175,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.854561984539032
  },
  {
    "title": "Walmart Earnings And The State Of The Consumer",
    "published": 1715836620,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 44.470001220703125,
      "2024-05-16T14:30:00+00:00": 43.99869918823242,
      "2024-05-16T15:30:00+00:00": 43.7400016784668,
      "2024-05-16T16:30:00+00:00": 43.93000030517578,
      "2024-05-16T17:30:00+00:00": 44.040000915527344,
      "2024-05-16T18:30:00+00:00": 44.140098571777344,
      "2024-05-16T19:30:00+00:00": 44.1150016784668
    },
    "sentiment": 0.8318517208099365
  },
  {
    "title": "Novartis boasts Scemblix beats tyrosine kinase inhibitors for chronic myeloid leukemia",
    "published": 1717154640,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 40.25,
      "2024-05-31T14:30:00+00:00": 40.744998931884766,
      "2024-05-31T15:30:00+00:00": 40.845001220703125,
      "2024-05-31T16:30:00+00:00": 41.03499984741211,
      "2024-05-31T17:30:00+00:00": 40.968299865722656,
      "2024-05-31T18:30:00+00:00": 41.05500030517578,
      "2024-05-31T19:30:00+00:00": 40.945499420166016
    },
    "sentiment": 0.7673794031143188
  },
  {
    "title": "Bristol Myers' Breyanzi approved by FDA as new CAR T cell therapy in MCL",
    "published": 1717146060,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 40.25,
      "2024-05-31T14:30:00+00:00": 40.744998931884766,
      "2024-05-31T15:30:00+00:00": 40.845001220703125,
      "2024-05-31T16:30:00+00:00": 41.03499984741211,
      "2024-05-31T17:30:00+00:00": 40.968299865722656,
      "2024-05-31T18:30:00+00:00": 41.05500030517578,
      "2024-05-31T19:30:00+00:00": 40.945499420166016
    },
    "sentiment": 0.7982284426689148
  },
  {
    "title": "6% Yield Bristol Myers Squibb Value Trap Or Long-Term Opportunity?",
    "published": 1717128000,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 40.25,
      "2024-05-31T14:30:00+00:00": 40.744998931884766,
      "2024-05-31T15:30:00+00:00": 40.845001220703125,
      "2024-05-31T16:30:00+00:00": 41.03499984741211,
      "2024-05-31T17:30:00+00:00": 40.968299865722656,
      "2024-05-31T18:30:00+00:00": 41.05500030517578,
      "2024-05-31T19:30:00+00:00": 40.945499420166016
    },
    "sentiment": 0.9033723473548889
  },
  {
    "title": "Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion",
    "published": 1717085700,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.6427467465400696
  },
  {
    "title": "Bristol Myers: FDA approval for Breyanzi",
    "published": 1717071738,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.8121939301490784
  },
  {
    "title": "US FDA allows use of Bristol's cell therapy for rare blood cancer",
    "published": 1717070131,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.8958755731582642
  },
  {
    "title": "Bristol Myers' Breyanzi gains additional indication for mantle cell lymphoma",
    "published": 1717068480,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 40.13999938964844,
      "2024-05-30T14:30:00+00:00": 40.25,
      "2024-05-30T15:30:00+00:00": 40.48780059814453,
      "2024-05-30T16:30:00+00:00": 40.37990188598633,
      "2024-05-30T17:30:00+00:00": 40.54499816894531,
      "2024-05-30T18:30:00+00:00": 40.43000030517578,
      "2024-05-30T19:30:00+00:00": 40.349998474121094
    },
    "sentiment": 0.8878174424171448
  },
  {
    "title": "BMS secures another EC approval for Opdivo combination",
    "published": 1716989215,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.9128811359405518
  },
  {
    "title": "Bristol-Myers receives Opdivo drug approval in Europe",
    "published": 1716986040,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.8794797658920288
  },
  {
    "title": "Bristol Myers: new EC approval for Opdivo",
    "published": 1716967597,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.8537294268608093
  },
  {
    "title": "Truist Financial Sticks to Their Buy Rating for Bristol-Myers Squibb (BMY)",
    "published": 1716965820,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.8393563628196716
  },
  {
    "title": "Bristol Myers Squibb (BMY) Shares Cross 6% Yield Mark",
    "published": 1716948900,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 40.279998779296875,
      "2024-05-29T14:30:00+00:00": 40.0099983215332,
      "2024-05-29T15:30:00+00:00": 40.5099983215332,
      "2024-05-29T16:30:00+00:00": 40.48500061035156,
      "2024-05-29T17:30:00+00:00": 40.525001525878906,
      "2024-05-29T18:30:00+00:00": 40.34000015258789,
      "2024-05-29T19:30:00+00:00": 40.40999984741211
    },
    "sentiment": 0.7013039588928223
  },
  {
    "title": "ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries",
    "published": 1716905700,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.7349245548248291
  },
  {
    "title": "Bank of America\u2019s \u2018triple momentum\u2019 screeners finds stocks including Nvidia, J.P.Morgan",
    "published": 1716889800,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.7072553038597107
  },
  {
    "title": "Bristol Myers licenses second compound from Prothena",
    "published": 1716866820,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.7815749645233154
  },
  {
    "title": "Bristol Myers Squibb Named Top Dividend Stock With Insider Buying and 5.82% Yield (BMY)",
    "published": 1716858900,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 41.220001220703125,
      "2024-05-28T14:30:00+00:00": 40.898799896240234,
      "2024-05-28T15:30:00+00:00": 40.937400817871094,
      "2024-05-28T16:30:00+00:00": 40.79999923706055,
      "2024-05-28T17:30:00+00:00": 40.5974006652832,
      "2024-05-28T18:30:00+00:00": 40.529998779296875,
      "2024-05-28T19:30:00+00:00": 40.439998626708984
    },
    "sentiment": 0.6060868501663208
  },
  {
    "title": "Bristol Myers: presents over 130 studies at ASCO",
    "published": 1716792984,
    "day_prices": {},
    "sentiment": 0.920741617679596
  },
  {
    "title": "S&P 500 Earnings Dashboard 24Q1 - Saturday, May 25",
    "published": 1716604200,
    "day_prices": {},
    "sentiment": 0.7771466374397278
  },
  {
    "title": "Retail Earnings & Consumer Spending: A Closer Look",
    "published": 1716549960,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 41.40999984741211,
      "2024-05-24T14:30:00+00:00": 41.290000915527344,
      "2024-05-24T15:30:00+00:00": 41.334598541259766,
      "2024-05-24T16:30:00+00:00": 41.45500183105469,
      "2024-05-24T17:30:00+00:00": 41.57500076293945,
      "2024-05-24T18:30:00+00:00": 41.29499816894531,
      "2024-05-24T19:30:00+00:00": 41.224998474121094
    },
    "sentiment": 0.8988534212112427
  },
  {
    "title": "Buy The Drop On These 6% Dividend Value Picks",
    "published": 1719648600,
    "day_prices": {},
    "sentiment": 0.5511910319328308
  },
  {
    "title": "SCHD: Time To Buy",
    "published": 1719573645,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 41.709999084472656,
      "2024-06-28T14:30:00+00:00": 42.189998626708984,
      "2024-06-28T15:30:00+00:00": 42.13999938964844,
      "2024-06-28T16:30:00+00:00": 41.99290084838867,
      "2024-06-28T17:30:00+00:00": 41.9900016784668,
      "2024-06-28T18:30:00+00:00": 41.94499969482422,
      "2024-06-28T19:30:00+00:00": 41.6150016784668
    },
    "sentiment": 0.8792067170143127
  },
  {
    "title": "5 Stocks I Sold Due To \"Fragile Stagflation\" Risk",
    "published": 1719559298,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 41.709999084472656,
      "2024-06-28T14:30:00+00:00": 42.189998626708984,
      "2024-06-28T15:30:00+00:00": 42.13999938964844,
      "2024-06-28T16:30:00+00:00": 41.99290084838867,
      "2024-06-28T17:30:00+00:00": 41.9900016784668,
      "2024-06-28T18:30:00+00:00": 41.94499969482422,
      "2024-06-28T19:30:00+00:00": 41.6150016784668
    },
    "sentiment": 0.6984252333641052
  },
  {
    "title": "You\u2019ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.",
    "published": 1719508495,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 42.43000030517578,
      "2024-06-27T14:30:00+00:00": 42.025001525878906,
      "2024-06-27T15:30:00+00:00": 42.029998779296875,
      "2024-06-27T16:30:00+00:00": 42.084999084472656,
      "2024-06-27T17:30:00+00:00": 41.8849983215332,
      "2024-06-27T18:30:00+00:00": 41.60499954223633,
      "2024-06-27T19:30:00+00:00": 41.560001373291016
    },
    "sentiment": 0.8092411756515503
  },
  {
    "title": "Novo Nordisk buys 2seventy bio\u2019s Hemophilia A program",
    "published": 1719468120,
    "day_prices": {
      "2024-06-27T13:30:00+00:00": 42.43000030517578,
      "2024-06-27T14:30:00+00:00": 42.025001525878906,
      "2024-06-27T15:30:00+00:00": 42.029998779296875,
      "2024-06-27T16:30:00+00:00": 42.084999084472656,
      "2024-06-27T17:30:00+00:00": 41.8849983215332,
      "2024-06-27T18:30:00+00:00": 41.60499954223633,
      "2024-06-27T19:30:00+00:00": 41.560001373291016
    },
    "sentiment": 0.9226241111755371
  },
  {
    "title": "CEO in Major Health-Advertising Fraud Gets 7.5-Year Prison Sentence",
    "published": 1719391560,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 42.11000061035156,
      "2024-06-26T14:30:00+00:00": 42.95500183105469,
      "2024-06-26T15:30:00+00:00": 42.564998626708984,
      "2024-06-26T16:30:00+00:00": 42.65999984741211,
      "2024-06-26T17:30:00+00:00": 42.54499816894531,
      "2024-06-26T18:30:00+00:00": 42.599998474121094,
      "2024-06-26T19:30:00+00:00": 42.56999969482422
    },
    "sentiment": 0.8327248096466064
  },
  {
    "title": "Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors",
    "published": 1719351918,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 42.02000045776367,
      "2024-06-25T14:30:00+00:00": 41.89500045776367,
      "2024-06-25T15:30:00+00:00": 42.290000915527344,
      "2024-06-25T16:30:00+00:00": 41.900001525878906,
      "2024-06-25T17:30:00+00:00": 41.96500015258789,
      "2024-06-25T18:30:00+00:00": 42.150001525878906,
      "2024-06-25T19:30:00+00:00": 42.22999954223633
    },
    "sentiment": 0.6183707118034363
  },
  {
    "title": "BMS expands Krazati\u2019s FDA label to include colorectal cancer",
    "published": 1719316386,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 42.02000045776367,
      "2024-06-25T14:30:00+00:00": 41.89500045776367,
      "2024-06-25T15:30:00+00:00": 42.290000915527344,
      "2024-06-25T16:30:00+00:00": 41.900001525878906,
      "2024-06-25T17:30:00+00:00": 41.96500015258789,
      "2024-06-25T18:30:00+00:00": 42.150001525878906,
      "2024-06-25T19:30:00+00:00": 42.22999954223633
    },
    "sentiment": 0.7986430525779724
  },
  {
    "title": "FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation",
    "published": 1719231958,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 42.0,
      "2024-06-24T14:30:00+00:00": 42.07500076293945,
      "2024-06-24T15:30:00+00:00": 41.939998626708984,
      "2024-06-24T16:30:00+00:00": 42.125,
      "2024-06-24T17:30:00+00:00": 42.095001220703125,
      "2024-06-24T18:30:00+00:00": 42.2599983215332,
      "2024-06-24T19:30:00+00:00": 42.10499954223633
    },
    "sentiment": 0.7142156362533569
  },
  {
    "title": "European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab",
    "published": 1719211635,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 42.0,
      "2024-06-24T14:30:00+00:00": 42.07500076293945,
      "2024-06-24T15:30:00+00:00": 41.939998626708984,
      "2024-06-24T16:30:00+00:00": 42.125,
      "2024-06-24T17:30:00+00:00": 42.095001220703125,
      "2024-06-24T18:30:00+00:00": 42.2599983215332,
      "2024-06-24T19:30:00+00:00": 42.10499954223633
    },
    "sentiment": 0.513208270072937
  },
  {
    "title": "Bristol Myers notes US FDA approval of Krazati for cancer form",
    "published": 1719191100,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 42.0,
      "2024-06-24T14:30:00+00:00": 42.07500076293945,
      "2024-06-24T15:30:00+00:00": 41.939998626708984,
      "2024-06-24T16:30:00+00:00": 42.125,
      "2024-06-24T17:30:00+00:00": 42.095001220703125,
      "2024-06-24T18:30:00+00:00": 42.2599983215332,
      "2024-06-24T19:30:00+00:00": 42.10499954223633
    },
    "sentiment": 0.9105649590492249
  },
  {
    "title": "Pfizer: Seriously Undervalued At Peak Pessimism",
    "published": 1719141213,
    "day_prices": {},
    "sentiment": 0.6736804842948914
  },
  {
    "title": "3 No-Brainer Stocks to Buy for Under $100 Right Now",
    "published": 1719054900,
    "day_prices": {},
    "sentiment": 0.9012323617935181
  },
  {
    "title": "Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI\u00ae (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)",
    "published": 1719012600,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 41.2599983215332,
      "2024-06-21T14:30:00+00:00": 41.66999816894531,
      "2024-06-21T15:30:00+00:00": 41.189998626708984,
      "2024-06-21T16:30:00+00:00": 41.14500045776367,
      "2024-06-21T17:30:00+00:00": 41.20000076293945,
      "2024-06-21T18:30:00+00:00": 41.52000045776367,
      "2024-06-21T19:30:00+00:00": 41.80500030517578
    },
    "sentiment": 0.9208555221557617
  },
  {
    "title": "IN BRIEF: Regulators validate Bristol Myers' Opdivo extension",
    "published": 1718979480,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 41.2599983215332,
      "2024-06-21T14:30:00+00:00": 41.66999816894531,
      "2024-06-21T15:30:00+00:00": 41.189998626708984,
      "2024-06-21T16:30:00+00:00": 41.14500045776367,
      "2024-06-21T17:30:00+00:00": 41.20000076293945,
      "2024-06-21T18:30:00+00:00": 41.52000045776367,
      "2024-06-21T19:30:00+00:00": 41.80500030517578
    },
    "sentiment": 0.9101235866546631
  },
  {
    "title": "FDA approves Mirati's Krazati sNDA for colorectal cancer",
    "published": 1718973780,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 41.2599983215332,
      "2024-06-21T14:30:00+00:00": 41.66999816894531,
      "2024-06-21T15:30:00+00:00": 41.189998626708984,
      "2024-06-21T16:30:00+00:00": 41.14500045776367,
      "2024-06-21T17:30:00+00:00": 41.20000076293945,
      "2024-06-21T18:30:00+00:00": 41.52000045776367,
      "2024-06-21T19:30:00+00:00": 41.80500030517578
    },
    "sentiment": 0.5791841149330139
  },
  {
    "title": "Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments",
    "published": 1718966760,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 41.2599983215332,
      "2024-06-21T14:30:00+00:00": 41.66999816894531,
      "2024-06-21T15:30:00+00:00": 41.189998626708984,
      "2024-06-21T16:30:00+00:00": 41.14500045776367,
      "2024-06-21T17:30:00+00:00": 41.20000076293945,
      "2024-06-21T18:30:00+00:00": 41.52000045776367,
      "2024-06-21T19:30:00+00:00": 41.80500030517578
    },
    "sentiment": 0.49734848737716675
  },
  {
    "title": "Bristol Myers Opdivo injectable accepted for EU review",
    "published": 1718951460,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 41.2599983215332,
      "2024-06-21T14:30:00+00:00": 41.66999816894531,
      "2024-06-21T15:30:00+00:00": 41.189998626708984,
      "2024-06-21T16:30:00+00:00": 41.14500045776367,
      "2024-06-21T17:30:00+00:00": 41.20000076293945,
      "2024-06-21T18:30:00+00:00": 41.52000045776367,
      "2024-06-21T19:30:00+00:00": 41.80500030517578
    },
    "sentiment": 0.8902265429496765
  },
  {
    "title": "Bristol-Myers wins FDA nod to expand label for cancer therapy Krazati",
    "published": 1718932080,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 41.2599983215332,
      "2024-06-21T14:30:00+00:00": 41.66999816894531,
      "2024-06-21T15:30:00+00:00": 41.189998626708984,
      "2024-06-21T16:30:00+00:00": 41.14500045776367,
      "2024-06-21T17:30:00+00:00": 41.20000076293945,
      "2024-06-21T18:30:00+00:00": 41.52000045776367,
      "2024-06-21T19:30:00+00:00": 41.80500030517578
    },
    "sentiment": 0.9265652894973755
  },
  {
    "title": "Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024",
    "published": 1718881140,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 40.54999923706055,
      "2024-06-20T14:30:00+00:00": 40.59000015258789,
      "2024-06-20T15:30:00+00:00": 40.709999084472656,
      "2024-06-20T16:30:00+00:00": 40.72999954223633,
      "2024-06-20T17:30:00+00:00": 40.80500030517578,
      "2024-06-20T18:30:00+00:00": 40.79999923706055,
      "2024-06-20T19:30:00+00:00": 41.04999923706055
    },
    "sentiment": 0.9308455586433411
  },
  {
    "title": "3 Warren Buffett Stocks to Buy Now: June 2024",
    "published": 1718821043,
    "day_prices": {},
    "sentiment": 0.9308607578277588
  },
  {
    "title": "Bristol-Myers Squibb Stock Price Forecast: Is The Downtrend Finally Over?",
    "published": 1718794680,
    "day_prices": {},
    "sentiment": 0.6794952750205994
  },
  {
    "title": "Bristol Myers: ex-CEO of Agilent joins Board of Directors",
    "published": 1718759475,
    "day_prices": {},
    "sentiment": 0.9001888632774353
  },
  {
    "title": "Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors",
    "published": 1718741760,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 41.02000045776367,
      "2024-06-18T14:30:00+00:00": 40.599998474121094,
      "2024-06-18T15:30:00+00:00": 40.724998474121094,
      "2024-06-18T16:30:00+00:00": 40.19499969482422,
      "2024-06-18T17:30:00+00:00": 40.5,
      "2024-06-18T18:30:00+00:00": 40.875,
      "2024-06-18T19:30:00+00:00": 40.845001220703125
    },
    "sentiment": 0.900842547416687
  },
  {
    "title": "Bristol Myers Squibb Announces Dividend",
    "published": 1718708340,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 41.02000045776367,
      "2024-06-18T14:30:00+00:00": 40.599998474121094,
      "2024-06-18T15:30:00+00:00": 40.724998474121094,
      "2024-06-18T16:30:00+00:00": 40.19499969482422,
      "2024-06-18T17:30:00+00:00": 40.5,
      "2024-06-18T18:30:00+00:00": 40.875,
      "2024-06-18T19:30:00+00:00": 40.845001220703125
    },
    "sentiment": 0.9250937104225159
  },
  {
    "title": "Bristol Myers: Board declares dividend",
    "published": 1718695577,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 41.02000045776367,
      "2024-06-18T14:30:00+00:00": 40.599998474121094,
      "2024-06-18T15:30:00+00:00": 40.724998474121094,
      "2024-06-18T16:30:00+00:00": 40.19499969482422,
      "2024-06-18T17:30:00+00:00": 40.5,
      "2024-06-18T18:30:00+00:00": 40.875,
      "2024-06-18T19:30:00+00:00": 40.845001220703125
    },
    "sentiment": 0.860107421875
  },
  {
    "title": "7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline",
    "published": 1718652476,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 41.06999969482422,
      "2024-06-17T14:30:00+00:00": 40.96500015258789,
      "2024-06-17T15:30:00+00:00": 40.994998931884766,
      "2024-06-17T16:30:00+00:00": 41.029998779296875,
      "2024-06-17T17:30:00+00:00": 41.005001068115234,
      "2024-06-17T18:30:00+00:00": 41.0,
      "2024-06-17T19:30:00+00:00": 40.834999084472656
    },
    "sentiment": 0.7924265265464783
  },
  {
    "title": "FDA grants approval for Bristol Myers Squibb\u2019s Augtyro for solid tumours",
    "published": 1718605940,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 41.06999969482422,
      "2024-06-17T14:30:00+00:00": 40.96500015258789,
      "2024-06-17T15:30:00+00:00": 40.994998931884766,
      "2024-06-17T16:30:00+00:00": 41.029998779296875,
      "2024-06-17T17:30:00+00:00": 41.005001068115234,
      "2024-06-17T18:30:00+00:00": 41.0,
      "2024-06-17T19:30:00+00:00": 40.834999084472656
    },
    "sentiment": 0.9059302806854248
  },
  {
    "title": "AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade)",
    "published": 1718449089,
    "day_prices": {},
    "sentiment": 0.6135511994361877
  },
  {
    "title": "Bloomsbury Publishing Announces Annual Report",
    "published": 1718364600,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 41.34000015258789,
      "2024-06-14T14:30:00+00:00": 40.88999938964844,
      "2024-06-14T15:30:00+00:00": 41.65999984741211,
      "2024-06-14T16:30:00+00:00": 41.775001525878906,
      "2024-06-14T17:30:00+00:00": 41.57500076293945,
      "2024-06-14T18:30:00+00:00": 41.525001525878906,
      "2024-06-14T19:30:00+00:00": 41.435001373291016
    },
    "sentiment": 0.923507571220398
  },
  {
    "title": "Bristol-Myers Squibb gets FDA approval for tumour drug Augtyro",
    "published": 1718342460,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 41.34000015258789,
      "2024-06-14T14:30:00+00:00": 40.88999938964844,
      "2024-06-14T15:30:00+00:00": 41.65999984741211,
      "2024-06-14T16:30:00+00:00": 41.775001525878906,
      "2024-06-14T17:30:00+00:00": 41.57500076293945,
      "2024-06-14T18:30:00+00:00": 41.525001525878906,
      "2024-06-14T19:30:00+00:00": 41.435001373291016
    },
    "sentiment": 0.8298971652984619
  },
  {
    "title": "Bristol Myers: FDA approval for treatment",
    "published": 1718332814,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 41.34000015258789,
      "2024-06-14T14:30:00+00:00": 40.88999938964844,
      "2024-06-14T15:30:00+00:00": 41.65999984741211,
      "2024-06-14T16:30:00+00:00": 41.775001525878906,
      "2024-06-14T17:30:00+00:00": 41.57500076293945,
      "2024-06-14T18:30:00+00:00": 41.525001525878906,
      "2024-06-14T19:30:00+00:00": 41.435001373291016
    },
    "sentiment": 0.8123828768730164
  },
  {
    "title": "Bristol Myers Squibb's Augtyro Gets FDA Accelerated Approval",
    "published": 1718299460,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 42.459999084472656,
      "2024-06-13T14:30:00+00:00": 41.53710174560547,
      "2024-06-13T15:30:00+00:00": 41.34000015258789,
      "2024-06-13T16:30:00+00:00": 41.32500076293945,
      "2024-06-13T17:30:00+00:00": 41.48500061035156,
      "2024-06-13T18:30:00+00:00": 41.529998779296875,
      "2024-06-13T19:30:00+00:00": 41.599998474121094
    },
    "sentiment": 0.7614777684211731
  },
  {
    "title": "Contineum: LPA1R Antagonist Drug Advancement Against IPF With Proven Track Model",
    "published": 1718287432,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 42.459999084472656,
      "2024-06-13T14:30:00+00:00": 41.53710174560547,
      "2024-06-13T15:30:00+00:00": 41.34000015258789,
      "2024-06-13T16:30:00+00:00": 41.32500076293945,
      "2024-06-13T17:30:00+00:00": 41.48500061035156,
      "2024-06-13T18:30:00+00:00": 41.529998779296875,
      "2024-06-13T19:30:00+00:00": 41.599998474121094
    },
    "sentiment": 0.8772227764129639
  },
  {
    "title": "August 2nd Options Now Available For Bristol Myers Squibb (BMY)",
    "published": 1718271720,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 42.459999084472656,
      "2024-06-13T14:30:00+00:00": 41.53710174560547,
      "2024-06-13T15:30:00+00:00": 41.34000015258789,
      "2024-06-13T16:30:00+00:00": 41.32500076293945,
      "2024-06-13T17:30:00+00:00": 41.48500061035156,
      "2024-06-13T18:30:00+00:00": 41.529998779296875,
      "2024-06-13T19:30:00+00:00": 41.599998474121094
    },
    "sentiment": 0.9465323686599731
  },
  {
    "title": "Bristol Myers gets FDA approval for Autyro for NTRK-positive cancers",
    "published": 1718253120,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 42.459999084472656,
      "2024-06-13T14:30:00+00:00": 41.53710174560547,
      "2024-06-13T15:30:00+00:00": 41.34000015258789,
      "2024-06-13T16:30:00+00:00": 41.32500076293945,
      "2024-06-13T17:30:00+00:00": 41.48500061035156,
      "2024-06-13T18:30:00+00:00": 41.529998779296875,
      "2024-06-13T19:30:00+00:00": 41.599998474121094
    },
    "sentiment": 0.8004507422447205
  },
  {
    "title": "TY: Massive Discount, But Variable Distribution Might Not Appeal To Everyone",
    "published": 1718189710,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 43.09000015258789,
      "2024-06-12T14:30:00+00:00": 42.38999938964844,
      "2024-06-12T15:30:00+00:00": 42.58000183105469,
      "2024-06-12T16:30:00+00:00": 42.61000061035156,
      "2024-06-12T17:30:00+00:00": 42.73500061035156,
      "2024-06-12T18:30:00+00:00": 42.77000045776367,
      "2024-06-12T19:30:00+00:00": 42.61000061035156
    },
    "sentiment": 0.8574905395507812
  },
  {
    "title": "Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know",
    "published": 1718142317,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 42.529998779296875,
      "2024-06-11T14:30:00+00:00": 42.20500183105469,
      "2024-06-11T15:30:00+00:00": 42.22999954223633,
      "2024-06-11T16:30:00+00:00": 42.665000915527344,
      "2024-06-11T17:30:00+00:00": 42.744998931884766,
      "2024-06-11T18:30:00+00:00": 42.749000549316406,
      "2024-06-11T19:30:00+00:00": 42.904998779296875
    },
    "sentiment": 0.8998105525970459
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global Healthcare Conference",
    "published": 1718116528,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 42.529998779296875,
      "2024-06-11T14:30:00+00:00": 42.20500183105469,
      "2024-06-11T15:30:00+00:00": 42.22999954223633,
      "2024-06-11T16:30:00+00:00": 42.665000915527344,
      "2024-06-11T17:30:00+00:00": 42.744998931884766,
      "2024-06-11T18:30:00+00:00": 42.749000549316406,
      "2024-06-11T19:30:00+00:00": 42.904998779296875
    },
    "sentiment": 0.9319618344306946
  },
  {
    "title": "3 Penny Stocks to Buy if You Want to Spend Less and Earn More",
    "published": 1718096520,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 42.529998779296875,
      "2024-06-11T14:30:00+00:00": 42.20500183105469,
      "2024-06-11T15:30:00+00:00": 42.22999954223633,
      "2024-06-11T16:30:00+00:00": 42.665000915527344,
      "2024-06-11T17:30:00+00:00": 42.744998931884766,
      "2024-06-11T18:30:00+00:00": 42.749000549316406,
      "2024-06-11T19:30:00+00:00": 42.904998779296875
    },
    "sentiment": 0.8977555632591248
  },
  {
    "title": "Tracking Baker Brothers Portfolio - Q1 2024 Update",
    "published": 1718065443,
    "day_prices": {
      "2024-06-11T13:30:00+00:00": 42.529998779296875,
      "2024-06-11T14:30:00+00:00": 42.20500183105469,
      "2024-06-11T15:30:00+00:00": 42.22999954223633,
      "2024-06-11T16:30:00+00:00": 42.665000915527344,
      "2024-06-11T17:30:00+00:00": 42.744998931884766,
      "2024-06-11T18:30:00+00:00": 42.749000549316406,
      "2024-06-11T19:30:00+00:00": 42.904998779296875
    },
    "sentiment": 0.9450036883354187
  },
  {
    "title": "7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)",
    "published": 1718017440,
    "day_prices": {
      "2024-06-10T13:30:00+00:00": 41.400001525878906,
      "2024-06-10T14:30:00+00:00": 41.814998626708984,
      "2024-06-10T15:30:00+00:00": 41.654998779296875,
      "2024-06-10T16:30:00+00:00": 41.94499969482422,
      "2024-06-10T17:30:00+00:00": 42.244998931884766,
      "2024-06-10T18:30:00+00:00": 42.3849983215332,
      "2024-06-10T19:30:00+00:00": 42.334999084472656
    },
    "sentiment": 0.9107916355133057
  },
  {
    "title": "Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476M",
    "published": 1717910100,
    "day_prices": {},
    "sentiment": 0.8252298831939697
  },
  {
    "title": "The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024",
    "published": 1717851600,
    "day_prices": {},
    "sentiment": 0.7153182029724121
  },
  {
    "title": "Investing $1 Million In An 8-Fund Portfolio Vs. An All-Stock Portfolio",
    "published": 1717839000,
    "day_prices": {},
    "sentiment": 0.8983703851699829
  },
  {
    "title": "Bristol Myers Squibb wins antitrust case against insurers regarding generics",
    "published": 1717838520,
    "day_prices": {},
    "sentiment": 0.7623016834259033
  },
  {
    "title": "Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million",
    "published": 1717809600,
    "day_prices": {},
    "sentiment": 0.7988827228546143
  },
  {
    "title": "Halozyme Therapeutics: The Story Brightens",
    "published": 1717756326,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 40.849998474121094,
      "2024-06-07T14:30:00+00:00": 41.435001373291016,
      "2024-06-07T15:30:00+00:00": 41.5,
      "2024-06-07T16:30:00+00:00": 41.1349983215332,
      "2024-06-07T17:30:00+00:00": 41.09429931640625,
      "2024-06-07T18:30:00+00:00": 41.15019989013672,
      "2024-06-07T19:30:00+00:00": 41.32500076293945
    },
    "sentiment": 0.5445643067359924
  },
  {
    "title": "LONDON BROKER RATINGS: Bryan Garnier raises ITM Power to 'neutral'",
    "published": 1717735500,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 40.849998474121094,
      "2024-06-07T14:30:00+00:00": 41.435001373291016,
      "2024-06-07T15:30:00+00:00": 41.5,
      "2024-06-07T16:30:00+00:00": 41.1349983215332,
      "2024-06-07T17:30:00+00:00": 41.09429931640625,
      "2024-06-07T18:30:00+00:00": 41.15019989013672,
      "2024-06-07T19:30:00+00:00": 41.32500076293945
    },
    "sentiment": 0.8933412432670593
  },
  {
    "title": "Goldman cuts 2seventy bio to neutral, cites competition concerns",
    "published": 1717667520,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 40.86000061035156,
      "2024-06-06T14:30:00+00:00": 40.970001220703125,
      "2024-06-06T15:30:00+00:00": 41.060001373291016,
      "2024-06-06T16:30:00+00:00": 41.1150016784668,
      "2024-06-06T17:30:00+00:00": 41.029998779296875,
      "2024-06-06T18:30:00+00:00": 40.940799713134766,
      "2024-06-06T19:30:00+00:00": 40.959999084472656
    },
    "sentiment": 0.6006227135658264
  },
  {
    "title": "BMY July 26th Options Begin Trading",
    "published": 1717666500,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 40.86000061035156,
      "2024-06-06T14:30:00+00:00": 40.970001220703125,
      "2024-06-06T15:30:00+00:00": 41.060001373291016,
      "2024-06-06T16:30:00+00:00": 41.1150016784668,
      "2024-06-06T17:30:00+00:00": 41.029998779296875,
      "2024-06-06T18:30:00+00:00": 40.940799713134766,
      "2024-06-06T19:30:00+00:00": 40.959999084472656
    },
    "sentiment": 0.9339483976364136
  },
  {
    "title": "I-Mab and BMS assess givastomig for gastric and oesophageal cancer",
    "published": 1717663550,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 40.86000061035156,
      "2024-06-06T14:30:00+00:00": 40.970001220703125,
      "2024-06-06T15:30:00+00:00": 41.060001373291016,
      "2024-06-06T16:30:00+00:00": 41.1150016784668,
      "2024-06-06T17:30:00+00:00": 41.029998779296875,
      "2024-06-06T18:30:00+00:00": 40.940799713134766,
      "2024-06-06T19:30:00+00:00": 40.959999084472656
    },
    "sentiment": 0.9046702980995178
  },
  {
    "title": "Here\u2019s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)",
    "published": 1717595350,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 41.68000030517578,
      "2024-06-05T14:30:00+00:00": 41.06999969482422,
      "2024-06-05T15:30:00+00:00": 41.224998474121094,
      "2024-06-05T16:30:00+00:00": 41.15999984741211,
      "2024-06-05T17:30:00+00:00": 41.20000076293945,
      "2024-06-05T18:30:00+00:00": 41.138099670410156,
      "2024-06-05T19:30:00+00:00": 41.18000030517578
    },
    "sentiment": 0.9316375255584717
  },
  {
    "title": "Envisagenics Raises Series B to Fuel AI-Enabled Novel Therapeutic Pipeline and Expand Depth and Breadth of Commercial Offerings",
    "published": 1717579800,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 41.68000030517578,
      "2024-06-05T14:30:00+00:00": 41.06999969482422,
      "2024-06-05T15:30:00+00:00": 41.224998474121094,
      "2024-06-05T16:30:00+00:00": 41.15999984741211,
      "2024-06-05T17:30:00+00:00": 41.20000076293945,
      "2024-06-05T18:30:00+00:00": 41.138099670410156,
      "2024-06-05T19:30:00+00:00": 41.18000030517578
    },
    "sentiment": 0.880649745464325
  },
  {
    "title": "Bristol Myers Squibb Announces Opdivo Plus Yervoy Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma",
    "published": 1717572557,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 41.68000030517578,
      "2024-06-05T14:30:00+00:00": 41.06999969482422,
      "2024-06-05T15:30:00+00:00": 41.224998474121094,
      "2024-06-05T16:30:00+00:00": 41.15999984741211,
      "2024-06-05T17:30:00+00:00": 41.20000076293945,
      "2024-06-05T18:30:00+00:00": 41.138099670410156,
      "2024-06-05T19:30:00+00:00": 41.18000030517578
    },
    "sentiment": 0.9536365866661072
  },
  {
    "title": "Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)",
    "published": 1717567800,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 41.68000030517578,
      "2024-06-05T14:30:00+00:00": 41.06999969482422,
      "2024-06-05T15:30:00+00:00": 41.224998474121094,
      "2024-06-05T16:30:00+00:00": 41.15999984741211,
      "2024-06-05T17:30:00+00:00": 41.20000076293945,
      "2024-06-05T18:30:00+00:00": 41.138099670410156,
      "2024-06-05T19:30:00+00:00": 41.18000030517578
    },
    "sentiment": 0.8848214149475098
  },
  {
    "title": "Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo",
    "published": 1717521420,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 41.75,
      "2024-06-04T14:30:00+00:00": 41.959999084472656,
      "2024-06-04T15:30:00+00:00": 41.7599983215332,
      "2024-06-04T16:30:00+00:00": 41.83000183105469,
      "2024-06-04T17:30:00+00:00": 41.834999084472656,
      "2024-06-04T18:30:00+00:00": 41.875,
      "2024-06-04T19:30:00+00:00": 41.70000076293945
    },
    "sentiment": 0.7495608329772949
  },
  {
    "title": "Schrodinger: Buy The Drug-Discovery Platform And Get The Pipeline Nearly For Free",
    "published": 1717500058,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 41.75,
      "2024-06-04T14:30:00+00:00": 41.959999084472656,
      "2024-06-04T15:30:00+00:00": 41.7599983215332,
      "2024-06-04T16:30:00+00:00": 41.83000183105469,
      "2024-06-04T17:30:00+00:00": 41.834999084472656,
      "2024-06-04T18:30:00+00:00": 41.875,
      "2024-06-04T19:30:00+00:00": 41.70000076293945
    },
    "sentiment": 0.7742515206336975
  },
  {
    "title": "Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference",
    "published": 1717498740,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 41.75,
      "2024-06-04T14:30:00+00:00": 41.959999084472656,
      "2024-06-04T15:30:00+00:00": 41.7599983215332,
      "2024-06-04T16:30:00+00:00": 41.83000183105469,
      "2024-06-04T17:30:00+00:00": 41.834999084472656,
      "2024-06-04T18:30:00+00:00": 41.875,
      "2024-06-04T19:30:00+00:00": 41.70000076293945
    },
    "sentiment": 0.8062363862991333
  },
  {
    "title": "Bristol Myers Squibb\u2019s Breyanzi shows promise in B-cell malignancy clinical trials",
    "published": 1717496801,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 41.75,
      "2024-06-04T14:30:00+00:00": 41.959999084472656,
      "2024-06-04T15:30:00+00:00": 41.7599983215332,
      "2024-06-04T16:30:00+00:00": 41.83000183105469,
      "2024-06-04T17:30:00+00:00": 41.834999084472656,
      "2024-06-04T18:30:00+00:00": 41.875,
      "2024-06-04T19:30:00+00:00": 41.70000076293945
    },
    "sentiment": 0.9173142910003662
  },
  {
    "title": "Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84%",
    "published": 1717491600,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 41.75,
      "2024-06-04T14:30:00+00:00": 41.959999084472656,
      "2024-06-04T15:30:00+00:00": 41.7599983215332,
      "2024-06-04T16:30:00+00:00": 41.83000183105469,
      "2024-06-04T17:30:00+00:00": 41.834999084472656,
      "2024-06-04T18:30:00+00:00": 41.875,
      "2024-06-04T19:30:00+00:00": 41.70000076293945
    },
    "sentiment": 0.7811123728752136
  },
  {
    "title": "Bristol Myers: Opdivo+Yervoy improved OS vs Lenvatinib or Sorafenib in HCC",
    "published": 1717484820,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 41.75,
      "2024-06-04T14:30:00+00:00": 41.959999084472656,
      "2024-06-04T15:30:00+00:00": 41.7599983215332,
      "2024-06-04T16:30:00+00:00": 41.83000183105469,
      "2024-06-04T17:30:00+00:00": 41.834999084472656,
      "2024-06-04T18:30:00+00:00": 41.875,
      "2024-06-04T19:30:00+00:00": 41.70000076293945
    },
    "sentiment": 0.9336552023887634
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Xeris Pharmaceuticals (XERS) and Bristol-Myers Squibb (BMY)",
    "published": 1717471860,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 41.75,
      "2024-06-04T14:30:00+00:00": 41.959999084472656,
      "2024-06-04T15:30:00+00:00": 41.7599983215332,
      "2024-06-04T16:30:00+00:00": 41.83000183105469,
      "2024-06-04T17:30:00+00:00": 41.834999084472656,
      "2024-06-04T18:30:00+00:00": 41.875,
      "2024-06-04T19:30:00+00:00": 41.70000076293945
    },
    "sentiment": 0.9204421639442444
  },
  {
    "title": "Bristol-Myers Squibb Says Breyanzi Studies Show 'Meaningful' Outcomes Across B-cell Malignancies",
    "published": 1717436312,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 41.15999984741211,
      "2024-06-03T14:30:00+00:00": 42.189998626708984,
      "2024-06-03T15:30:00+00:00": 42.185001373291016,
      "2024-06-03T16:30:00+00:00": 41.880001068115234,
      "2024-06-03T17:30:00+00:00": 41.744998931884766,
      "2024-06-03T18:30:00+00:00": 42.02000045776367,
      "2024-06-03T19:30:00+00:00": 41.904998779296875
    },
    "sentiment": 0.9552564024925232
  },
  {
    "title": "Bristol Myers' Breyanzi shown effective against b-cell lymphoma",
    "published": 1717426620,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 41.15999984741211,
      "2024-06-03T14:30:00+00:00": 42.189998626708984,
      "2024-06-03T15:30:00+00:00": 42.185001373291016,
      "2024-06-03T16:30:00+00:00": 41.880001068115234,
      "2024-06-03T17:30:00+00:00": 41.744998931884766,
      "2024-06-03T18:30:00+00:00": 42.02000045776367,
      "2024-06-03T19:30:00+00:00": 41.904998779296875
    },
    "sentiment": 0.9457022547721863
  },
  {
    "title": "Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO\u00ae Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer",
    "published": 1717416000,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 41.15999984741211,
      "2024-06-03T14:30:00+00:00": 42.189998626708984,
      "2024-06-03T15:30:00+00:00": 42.185001373291016,
      "2024-06-03T16:30:00+00:00": 41.880001068115234,
      "2024-06-03T17:30:00+00:00": 41.744998931884766,
      "2024-06-03T18:30:00+00:00": 42.02000045776367,
      "2024-06-03T19:30:00+00:00": 41.904998779296875
    },
    "sentiment": 0.795322835445404
  },
  {
    "title": "Bristol's Breyanzi demonstrates efficacy across a range of B-cell malignancies",
    "published": 1717411200,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 41.15999984741211,
      "2024-06-03T14:30:00+00:00": 42.189998626708984,
      "2024-06-03T15:30:00+00:00": 42.185001373291016,
      "2024-06-03T16:30:00+00:00": 41.880001068115234,
      "2024-06-03T17:30:00+00:00": 41.744998931884766,
      "2024-06-03T18:30:00+00:00": 42.02000045776367,
      "2024-06-03T19:30:00+00:00": 41.904998779296875
    },
    "sentiment": 0.9185624718666077
  },
  {
    "title": "Bristol's Breyanzi demonstrates efficacy across range of B-cell malignancies",
    "published": 1717409520,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 41.15999984741211,
      "2024-06-03T14:30:00+00:00": 42.189998626708984,
      "2024-06-03T15:30:00+00:00": 42.185001373291016,
      "2024-06-03T16:30:00+00:00": 41.880001068115234,
      "2024-06-03T17:30:00+00:00": 41.744998931884766,
      "2024-06-03T18:30:00+00:00": 42.02000045776367,
      "2024-06-03T19:30:00+00:00": 41.904998779296875
    },
    "sentiment": 0.9284252524375916
  },
  {
    "title": "Bristol Myers: presents advances in lung cancer",
    "published": 1717405113,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 41.15999984741211,
      "2024-06-03T14:30:00+00:00": 42.189998626708984,
      "2024-06-03T15:30:00+00:00": 42.185001373291016,
      "2024-06-03T16:30:00+00:00": 41.880001068115234,
      "2024-06-03T17:30:00+00:00": 41.744998931884766,
      "2024-06-03T18:30:00+00:00": 42.02000045776367,
      "2024-06-03T19:30:00+00:00": 41.904998779296875
    },
    "sentiment": 0.5955027937889099
  },
  {
    "title": "UroGen Pharma announces David Lin as chief commercial officer",
    "published": 1717398240,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 41.15999984741211,
      "2024-06-03T14:30:00+00:00": 42.189998626708984,
      "2024-06-03T15:30:00+00:00": 42.185001373291016,
      "2024-06-03T16:30:00+00:00": 41.880001068115234,
      "2024-06-03T17:30:00+00:00": 41.744998931884766,
      "2024-06-03T18:30:00+00:00": 42.02000045776367,
      "2024-06-03T19:30:00+00:00": 41.904998779296875
    },
    "sentiment": 0.9179568290710449
  },
  {
    "title": "Bristol Myers announces results from Phase 3 KRYSTAL-12 study",
    "published": 1717307400,
    "day_prices": {},
    "sentiment": 0.7871782779693604
  },
  {
    "title": "KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer",
    "published": 1717243200,
    "day_prices": {},
    "sentiment": 0.9518857002258301
  },
  {
    "title": "Bristol Myers lung cancer drug Krazati succeeds in late-stage trial",
    "published": 1717228740,
    "day_prices": {},
    "sentiment": 0.594167172908783
  },
  {
    "title": "Argus Research Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)",
    "published": 1722421080,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 48.5,
      "2024-07-31T14:30:00+00:00": 48.77000045776367,
      "2024-07-31T15:30:00+00:00": 48.40999984741211,
      "2024-07-31T16:30:00+00:00": 48.29999923706055,
      "2024-07-31T17:30:00+00:00": 48.18000030517578,
      "2024-07-31T18:30:00+00:00": 48.084999084472656,
      "2024-07-31T19:30:00+00:00": 47.63999938964844
    },
    "sentiment": 0.8765231370925903
  },
  {
    "title": "Fidelity Freedom 2040 Fund Q2 2024 Review",
    "published": 1722404100,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 48.5,
      "2024-07-31T14:30:00+00:00": 48.77000045776367,
      "2024-07-31T15:30:00+00:00": 48.40999984741211,
      "2024-07-31T16:30:00+00:00": 48.29999923706055,
      "2024-07-31T17:30:00+00:00": 48.18000030517578,
      "2024-07-31T18:30:00+00:00": 48.084999084472656,
      "2024-07-31T19:30:00+00:00": 47.63999938964844
    },
    "sentiment": 0.9496800899505615
  },
  {
    "title": "BMY vs. VRTX: Which Stock Should Value Investors Buy Now?",
    "published": 1722354011,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 49.060001373291016,
      "2024-07-30T14:30:00+00:00": 48.029998779296875,
      "2024-07-30T15:30:00+00:00": 48.349998474121094,
      "2024-07-30T16:30:00+00:00": 48.814998626708984,
      "2024-07-30T17:30:00+00:00": 48.939998626708984,
      "2024-07-30T18:30:00+00:00": 48.91999816894531,
      "2024-07-30T19:30:00+00:00": 49.185001373291016
    },
    "sentiment": 0.9316627979278564
  },
  {
    "title": "Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1722344416,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 49.060001373291016,
      "2024-07-30T14:30:00+00:00": 48.029998779296875,
      "2024-07-30T15:30:00+00:00": 48.349998474121094,
      "2024-07-30T16:30:00+00:00": 48.814998626708984,
      "2024-07-30T17:30:00+00:00": 48.939998626708984,
      "2024-07-30T18:30:00+00:00": 48.91999816894531,
      "2024-07-30T19:30:00+00:00": 49.185001373291016
    },
    "sentiment": 0.9115446209907532
  },
  {
    "title": "Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer",
    "published": 1722338100,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 49.060001373291016,
      "2024-07-30T14:30:00+00:00": 48.029998779296875,
      "2024-07-30T15:30:00+00:00": 48.349998474121094,
      "2024-07-30T16:30:00+00:00": 48.814998626708984,
      "2024-07-30T17:30:00+00:00": 48.939998626708984,
      "2024-07-30T18:30:00+00:00": 48.91999816894531,
      "2024-07-30T19:30:00+00:00": 49.185001373291016
    },
    "sentiment": 0.8931597471237183
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Bristol Myers Squibb",
    "published": 1722334860,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 49.060001373291016,
      "2024-07-30T14:30:00+00:00": 48.029998779296875,
      "2024-07-30T15:30:00+00:00": 48.349998474121094,
      "2024-07-30T16:30:00+00:00": 48.814998626708984,
      "2024-07-30T17:30:00+00:00": 48.939998626708984,
      "2024-07-30T18:30:00+00:00": 48.91999816894531,
      "2024-07-30T19:30:00+00:00": 49.185001373291016
    },
    "sentiment": 0.9449505805969238
  },
  {
    "title": "Pfizer stock gains after raising annual earnings outlook",
    "published": 1722320340,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 49.060001373291016,
      "2024-07-30T14:30:00+00:00": 48.029998779296875,
      "2024-07-30T15:30:00+00:00": 48.349998474121094,
      "2024-07-30T16:30:00+00:00": 48.814998626708984,
      "2024-07-30T17:30:00+00:00": 48.939998626708984,
      "2024-07-30T18:30:00+00:00": 48.91999816894531,
      "2024-07-30T19:30:00+00:00": 49.185001373291016
    },
    "sentiment": 0.9412181973457336
  },
  {
    "title": "Bristol-Myers Squibb: A Cautious Hold Amidst Uneven Growth Prospects",
    "published": 1722303420,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 49.060001373291016,
      "2024-07-30T14:30:00+00:00": 48.029998779296875,
      "2024-07-30T15:30:00+00:00": 48.349998474121094,
      "2024-07-30T16:30:00+00:00": 48.814998626708984,
      "2024-07-30T17:30:00+00:00": 48.939998626708984,
      "2024-07-30T18:30:00+00:00": 48.91999816894531,
      "2024-07-30T19:30:00+00:00": 49.185001373291016
    },
    "sentiment": 0.8037413954734802
  },
  {
    "title": "Bristol-Myers Squibb Earnings Reinforces Our Thesis",
    "published": 1722263860,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.4329058825969696
  },
  {
    "title": "AbbVie: Growth Is Still A Better Choice",
    "published": 1722255579,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.8478158712387085
  },
  {
    "title": "Bristol Myers Squibb reports dip in net income for Q2 2024",
    "published": 1722241945,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.9704362154006958
  },
  {
    "title": "Healthcare Stocks Are Coming On Strong In July Led By Biotech",
    "published": 1722238080,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.9418980479240417
  },
  {
    "title": "Alphabet upgraded, Arm downgraded: Wall Street's top analyst calls",
    "published": 1722238080,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.5028434991836548
  },
  {
    "title": "Bristol Myers Squibb Reports Second Quarter Financial Results for 2024",
    "published": 1722234921,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.7981545329093933
  },
  {
    "title": "Barclays downgrades Bristol Myers to Underweight after 25% share rally",
    "published": 1722232020,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.9300479888916016
  },
  {
    "title": "Barclays cuts Bristol Myers to underweight, cites recent run up",
    "published": 1722223380,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 49.91999816894531,
      "2024-07-29T14:30:00+00:00": 50.685001373291016,
      "2024-07-29T15:30:00+00:00": 50.564998626708984,
      "2024-07-29T16:30:00+00:00": 50.3650016784668,
      "2024-07-29T17:30:00+00:00": 49.869998931884766,
      "2024-07-29T18:30:00+00:00": 49.43560028076172,
      "2024-07-29T19:30:00+00:00": 49.23500061035156
    },
    "sentiment": 0.8445507884025574
  },
  {
    "title": "Why Wall Street is unfazed by Medicare drug pricing threat",
    "published": 1722094279,
    "day_prices": {},
    "sentiment": 0.8312684893608093
  },
  {
    "title": "Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point",
    "published": 1722068959,
    "day_prices": {},
    "sentiment": 0.8956094980239868
  },
  {
    "title": "Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win",
    "published": 1722005260,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.5705097913742065
  },
  {
    "title": "These Stocks Are Moving the Most Today: DexCom, Deckers, Ford, Nvidia, Alphabet, Coursera, Bristol Myers, 3M, and More",
    "published": 1721987940,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8136219382286072
  },
  {
    "title": "Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript",
    "published": 1722011418,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9197911024093628
  },
  {
    "title": "Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge",
    "published": 1722009813,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.632013738155365
  },
  {
    "title": "Bristol Myers Stock Rises Sharply. A Sales Jump for Eliquis Boosts Earnings.",
    "published": 1722005760,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8071168065071106
  },
  {
    "title": "Bristol-Myers Squibb Beats Q2 Expectations, Boosts Guidance on Rising Drug Sales",
    "published": 1722004565,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9389813542366028
  },
  {
    "title": "Bristol-Myers (BMY) Tops on Q2 Earnings, Ups '24 EPS View",
    "published": 1722003060,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8700955510139465
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY) Q2 2024 Earnings Call Transcript",
    "published": 1721999736,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9134932160377502
  },
  {
    "title": "Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast",
    "published": 1721995714,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9532361626625061
  },
  {
    "title": "Bristol Myers\u2019 beat completes strong week of pharma earnings",
    "published": 1721994900,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8989001512527466
  },
  {
    "title": "Stocks To Watch Today: 3M, BMY, And Coursera Inc.",
    "published": 1721993160,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9286779761314392
  },
  {
    "title": "Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results",
    "published": 1721991900,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9703105092048645
  },
  {
    "title": "BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024",
    "published": 1721991480,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.850334107875824
  },
  {
    "title": "Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday",
    "published": 1721988600,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9373429417610168
  },
  {
    "title": "BMY Crosses Above Key Moving Average Level",
    "published": 1721987580,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8851073980331421
  },
  {
    "title": "Unusually active option classes on open July 26th",
    "published": 1721983200,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.7423473596572876
  },
  {
    "title": "Morning Brew: Keytruda Combo Therapy Endorsed by EMA, BMY's Phase 3 Win, and More",
    "published": 1721980020,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8024663329124451
  },
  {
    "title": "Bristol Myers Squibb raises full-year targets",
    "published": 1721979081,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8252150416374207
  },
  {
    "title": "Bristol-Myers Squibb Co (BMY) Q2 2024 Earnings: Revenue Surpasses Estimates at $12. ...",
    "published": 1721977920,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9389196634292603
  },
  {
    "title": "Earnings summary: Bristol-Myers Squibb Q2 results top estimates, raises adj. EPS outlook",
    "published": 1721974920,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.8816664814949036
  },
  {
    "title": "Bristol Myers raises FY24 adj. EPS view to 60c-90c from 40c-70c, consensus 51c",
    "published": 1721973720,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.9069462418556213
  },
  {
    "title": "Top 10 U.S. stocks with 3-month earnings momentum as net upgrades brighten: Berenberg",
    "published": 1721972820,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.6254634857177734
  },
  {
    "title": "S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone",
    "published": 1721963220,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.964839518070221
  },
  {
    "title": "Dow Rises More Than 700 Points",
    "published": 1721956620,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 48.27000045776367,
      "2024-07-26T14:30:00+00:00": 48.869998931884766,
      "2024-07-26T15:30:00+00:00": 49.349998474121094,
      "2024-07-26T16:30:00+00:00": 49.20970153808594,
      "2024-07-26T17:30:00+00:00": 49.875,
      "2024-07-26T18:30:00+00:00": 50.185001373291016,
      "2024-07-26T19:30:00+00:00": 50.119998931884766
    },
    "sentiment": 0.7066458463668823
  },
  {
    "title": "Bristol-Myers Squibb Q2 Earnings Preview: Strong results on the back of legacy portfolio",
    "published": 1721902500,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 44.720001220703125,
      "2024-07-25T14:30:00+00:00": 45.34000015258789,
      "2024-07-25T15:30:00+00:00": 45.334999084472656,
      "2024-07-25T16:30:00+00:00": 45.380001068115234,
      "2024-07-25T17:30:00+00:00": 45.4900016784668,
      "2024-07-25T18:30:00+00:00": 44.97999954223633,
      "2024-07-25T19:30:00+00:00": 45.26499938964844
    },
    "sentiment": 0.9513993859291077
  },
  {
    "title": "What Lies in Store for Healthcare ETFs in Q2 Earnings?",
    "published": 1721833200,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 43.25,
      "2024-07-24T14:30:00+00:00": 43.45500183105469,
      "2024-07-24T15:30:00+00:00": 43.834999084472656,
      "2024-07-24T16:30:00+00:00": 44.310001373291016,
      "2024-07-24T17:30:00+00:00": 44.41999816894531,
      "2024-07-24T18:30:00+00:00": 44.42499923706055,
      "2024-07-24T19:30:00+00:00": 44.689998626708984
    },
    "sentiment": 0.8512557744979858
  },
  {
    "title": "Pharma aims to deliver personalized cancer therapies more quickly",
    "published": 1721800800,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 43.25,
      "2024-07-24T14:30:00+00:00": 43.45500183105469,
      "2024-07-24T15:30:00+00:00": 43.834999084472656,
      "2024-07-24T16:30:00+00:00": 44.310001373291016,
      "2024-07-24T17:30:00+00:00": 44.41999816894531,
      "2024-07-24T18:30:00+00:00": 44.42499923706055,
      "2024-07-24T19:30:00+00:00": 44.689998626708984
    },
    "sentiment": 0.5239306688308716
  },
  {
    "title": "Newly-Listed Psoriasis Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation",
    "published": 1721787780,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 43.25,
      "2024-07-24T14:30:00+00:00": 43.45500183105469,
      "2024-07-24T15:30:00+00:00": 43.834999084472656,
      "2024-07-24T16:30:00+00:00": 44.310001373291016,
      "2024-07-24T17:30:00+00:00": 44.41999816894531,
      "2024-07-24T18:30:00+00:00": 44.42499923706055,
      "2024-07-24T19:30:00+00:00": 44.689998626708984
    },
    "sentiment": 0.9506088495254517
  },
  {
    "title": "Hold Rating on Bristol-Myers Squibb Amid Mixed Performance and Evolving Pipeline",
    "published": 1721715960,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 42.439998626708984,
      "2024-07-23T14:30:00+00:00": 42.025001525878906,
      "2024-07-23T15:30:00+00:00": 41.97999954223633,
      "2024-07-23T16:30:00+00:00": 42.04499816894531,
      "2024-07-23T17:30:00+00:00": 42.224998474121094,
      "2024-07-23T18:30:00+00:00": 42.415000915527344,
      "2024-07-23T19:30:00+00:00": 42.73500061035156
    },
    "sentiment": 0.9581556916236877
  },
  {
    "title": "Alumis initiated with bullish view at Leerink, here's why",
    "published": 1721711820,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 42.439998626708984,
      "2024-07-23T14:30:00+00:00": 42.025001525878906,
      "2024-07-23T15:30:00+00:00": 41.97999954223633,
      "2024-07-23T16:30:00+00:00": 42.04499816894531,
      "2024-07-23T17:30:00+00:00": 42.224998474121094,
      "2024-07-23T18:30:00+00:00": 42.415000915527344,
      "2024-07-23T19:30:00+00:00": 42.73500061035156
    },
    "sentiment": 0.7990731000900269
  },
  {
    "title": "BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release",
    "published": 1721656862,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 42.43000030517578,
      "2024-07-22T14:30:00+00:00": 42.61000061035156,
      "2024-07-22T15:30:00+00:00": 42.915000915527344,
      "2024-07-22T16:30:00+00:00": 42.790000915527344,
      "2024-07-22T17:30:00+00:00": 42.71500015258789,
      "2024-07-22T18:30:00+00:00": 42.67499923706055,
      "2024-07-22T19:30:00+00:00": 42.63999938964844
    },
    "sentiment": 0.8909115195274353
  },
  {
    "title": "Investors in Bristol-Myers Squibb (NYSE:BMY) from three years ago are still down 30%, even after 5.4% gain this past week",
    "published": 1721570424,
    "day_prices": {},
    "sentiment": 0.9740400314331055
  },
  {
    "title": "3 Defensive Stocks to Shield Your Portfolio in July",
    "published": 1721458620,
    "day_prices": {},
    "sentiment": 0.9126730561256409
  },
  {
    "title": "7 Value Stocks to Buy at a 52-Week Low in July",
    "published": 1721417148,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 42.630001068115234,
      "2024-07-19T14:30:00+00:00": 41.85499954223633,
      "2024-07-19T15:30:00+00:00": 41.939998626708984,
      "2024-07-19T16:30:00+00:00": 42.334999084472656,
      "2024-07-19T17:30:00+00:00": 42.619998931884766,
      "2024-07-19T18:30:00+00:00": 42.775001525878906,
      "2024-07-19T19:30:00+00:00": 42.665000915527344
    },
    "sentiment": 0.8950303792953491
  },
  {
    "title": "Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma",
    "published": 1721386740,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 42.630001068115234,
      "2024-07-19T14:30:00+00:00": 41.85499954223633,
      "2024-07-19T15:30:00+00:00": 41.939998626708984,
      "2024-07-19T16:30:00+00:00": 42.334999084472656,
      "2024-07-19T17:30:00+00:00": 42.619998931884766,
      "2024-07-19T18:30:00+00:00": 42.775001525878906,
      "2024-07-19T19:30:00+00:00": 42.665000915527344
    },
    "sentiment": 0.9146316051483154
  },
  {
    "title": "Takeda's AI-Powered Strategy To Optimize Operations And Accelerate Its Pipeline",
    "published": 1721383000,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 42.630001068115234,
      "2024-07-19T14:30:00+00:00": 41.85499954223633,
      "2024-07-19T15:30:00+00:00": 41.939998626708984,
      "2024-07-19T16:30:00+00:00": 42.334999084472656,
      "2024-07-19T17:30:00+00:00": 42.619998931884766,
      "2024-07-19T18:30:00+00:00": 42.775001525878906,
      "2024-07-19T19:30:00+00:00": 42.665000915527344
    },
    "sentiment": 0.885672390460968
  },
  {
    "title": "Bristol Myers: application validated by the EMA in liver cancer",
    "published": 1721373640,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 42.630001068115234,
      "2024-07-19T14:30:00+00:00": 41.85499954223633,
      "2024-07-19T15:30:00+00:00": 41.939998626708984,
      "2024-07-19T16:30:00+00:00": 42.334999084472656,
      "2024-07-19T17:30:00+00:00": 42.619998931884766,
      "2024-07-19T18:30:00+00:00": 42.775001525878906,
      "2024-07-19T19:30:00+00:00": 42.665000915527344
    },
    "sentiment": 0.9101033210754395
  },
  {
    "title": "Bristol Myers' Opdivo combination in carcinoma receives EMA validation",
    "published": 1721368920,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 42.630001068115234,
      "2024-07-19T14:30:00+00:00": 41.85499954223633,
      "2024-07-19T15:30:00+00:00": 41.939998626708984,
      "2024-07-19T16:30:00+00:00": 42.334999084472656,
      "2024-07-19T17:30:00+00:00": 42.619998931884766,
      "2024-07-19T18:30:00+00:00": 42.775001525878906,
      "2024-07-19T19:30:00+00:00": 42.665000915527344
    },
    "sentiment": 0.7364963293075562
  },
  {
    "title": "Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors",
    "published": 1721339119,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 42.560699462890625,
      "2024-07-18T14:30:00+00:00": 43.95500183105469,
      "2024-07-18T15:30:00+00:00": 43.834999084472656,
      "2024-07-18T16:30:00+00:00": 43.85499954223633,
      "2024-07-18T17:30:00+00:00": 43.744998931884766,
      "2024-07-18T18:30:00+00:00": 42.994998931884766,
      "2024-07-18T19:30:00+00:00": 42.67499923706055
    },
    "sentiment": 0.5301682949066162
  },
  {
    "title": "Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability",
    "published": 1721297176,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 42.560699462890625,
      "2024-07-18T14:30:00+00:00": 43.95500183105469,
      "2024-07-18T15:30:00+00:00": 43.834999084472656,
      "2024-07-18T16:30:00+00:00": 43.85499954223633,
      "2024-07-18T17:30:00+00:00": 43.744998931884766,
      "2024-07-18T18:30:00+00:00": 42.994998931884766,
      "2024-07-18T19:30:00+00:00": 42.67499923706055
    },
    "sentiment": 0.8638252019882202
  },
  {
    "title": "Bristol Myers initiated with bearish view at Bocom",
    "published": 1721281620,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 42.560699462890625,
      "2024-07-18T14:30:00+00:00": 43.95500183105469,
      "2024-07-18T15:30:00+00:00": 43.834999084472656,
      "2024-07-18T16:30:00+00:00": 43.85499954223633,
      "2024-07-18T17:30:00+00:00": 43.744998931884766,
      "2024-07-18T18:30:00+00:00": 42.994998931884766,
      "2024-07-18T19:30:00+00:00": 42.67499923706055
    },
    "sentiment": 0.7850651741027832
  },
  {
    "title": "Is Bristol-Myers Squibb's Rich Dividend Yield Worth The Patent Cliff Correction Risk?",
    "published": 1721224800,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 41.20000076293945,
      "2024-07-17T14:30:00+00:00": 43.31999969482422,
      "2024-07-17T15:30:00+00:00": 42.92499923706055,
      "2024-07-17T16:30:00+00:00": 43.09189987182617,
      "2024-07-17T17:30:00+00:00": 42.79999923706055,
      "2024-07-17T18:30:00+00:00": 42.83000183105469,
      "2024-07-17T19:30:00+00:00": 42.974998474121094
    },
    "sentiment": 0.7898546457290649
  },
  {
    "title": "Bristol-Myers Squibb Reports Before the Open on 7/26 -- Options Contracts Expire the Same Day",
    "published": 1721216220,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 41.20000076293945,
      "2024-07-17T14:30:00+00:00": 43.31999969482422,
      "2024-07-17T15:30:00+00:00": 42.92499923706055,
      "2024-07-17T16:30:00+00:00": 43.09189987182617,
      "2024-07-17T17:30:00+00:00": 42.79999923706055,
      "2024-07-17T18:30:00+00:00": 42.83000183105469,
      "2024-07-17T19:30:00+00:00": 42.974998474121094
    },
    "sentiment": 0.8116145133972168
  },
  {
    "title": "Bristol Myers Squibb call volume above normal and directionally bullish",
    "published": 1721209500,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 41.20000076293945,
      "2024-07-17T14:30:00+00:00": 43.31999969482422,
      "2024-07-17T15:30:00+00:00": 42.92499923706055,
      "2024-07-17T16:30:00+00:00": 43.09189987182617,
      "2024-07-17T17:30:00+00:00": 42.79999923706055,
      "2024-07-17T18:30:00+00:00": 42.83000183105469,
      "2024-07-17T19:30:00+00:00": 42.974998474121094
    },
    "sentiment": 0.8764194846153259
  },
  {
    "title": "BMS Named 2024 Best Place to Work for Disability Inclusion in US, UK and Brazil by the Disability Equality Index\u00ae",
    "published": 1721208614,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 41.20000076293945,
      "2024-07-17T14:30:00+00:00": 43.31999969482422,
      "2024-07-17T15:30:00+00:00": 42.92499923706055,
      "2024-07-17T16:30:00+00:00": 43.09189987182617,
      "2024-07-17T17:30:00+00:00": 42.79999923706055,
      "2024-07-17T18:30:00+00:00": 42.83000183105469,
      "2024-07-17T19:30:00+00:00": 42.974998474121094
    },
    "sentiment": 0.8712928295135498
  },
  {
    "title": "IN BRIEF: Bloomsbury Publishing confident after US academic purchase",
    "published": 1721118000,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 40.150001525878906,
      "2024-07-16T14:30:00+00:00": 40.6150016784668,
      "2024-07-16T15:30:00+00:00": 40.72999954223633,
      "2024-07-16T16:30:00+00:00": 40.95000076293945,
      "2024-07-16T17:30:00+00:00": 40.99169921875,
      "2024-07-16T18:30:00+00:00": 41.08000183105469,
      "2024-07-16T19:30:00+00:00": 41.15380096435547
    },
    "sentiment": 0.9401090145111084
  },
  {
    "title": "High Dividend 50: Bristol-Myers Squibb",
    "published": 1721116800,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 40.150001525878906,
      "2024-07-16T14:30:00+00:00": 40.6150016784668,
      "2024-07-16T15:30:00+00:00": 40.72999954223633,
      "2024-07-16T16:30:00+00:00": 40.95000076293945,
      "2024-07-16T17:30:00+00:00": 40.99169921875,
      "2024-07-16T18:30:00+00:00": 41.08000183105469,
      "2024-07-16T19:30:00+00:00": 41.15380096435547
    },
    "sentiment": 0.9065428376197815
  },
  {
    "title": "LONDON BRIEFING: Lower start; Powell sees inflation coming down",
    "published": 1721099280,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 40.150001525878906,
      "2024-07-16T14:30:00+00:00": 40.6150016784668,
      "2024-07-16T15:30:00+00:00": 40.72999954223633,
      "2024-07-16T16:30:00+00:00": 40.95000076293945,
      "2024-07-16T17:30:00+00:00": 40.99169921875,
      "2024-07-16T18:30:00+00:00": 41.08000183105469,
      "2024-07-16T19:30:00+00:00": 41.15380096435547
    },
    "sentiment": 0.8720173239707947
  },
  {
    "title": "GET READY: Rio Tinto, Experian, Ocado, IntegraFin at 0700 BST",
    "published": 1721093820,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 40.150001525878906,
      "2024-07-16T14:30:00+00:00": 40.6150016784668,
      "2024-07-16T15:30:00+00:00": 40.72999954223633,
      "2024-07-16T16:30:00+00:00": 40.95000076293945,
      "2024-07-16T17:30:00+00:00": 40.99169921875,
      "2024-07-16T18:30:00+00:00": 41.08000183105469,
      "2024-07-16T19:30:00+00:00": 41.15380096435547
    },
    "sentiment": 0.9292149543762207
  },
  {
    "title": "Bristol-Myers Squibb: Seriously Undervalued And Poised For An Inflection",
    "published": 1721033129,
    "day_prices": {
      "2024-07-15T13:30:00+00:00": 40.630001068115234,
      "2024-07-15T14:30:00+00:00": 40.13990020751953,
      "2024-07-15T15:30:00+00:00": 40.134498596191406,
      "2024-07-15T16:30:00+00:00": 40.345001220703125,
      "2024-07-15T17:30:00+00:00": 40.18009948730469,
      "2024-07-15T18:30:00+00:00": 40.005001068115234,
      "2024-07-15T19:30:00+00:00": 40.125
    },
    "sentiment": 0.9361297488212585
  },
  {
    "title": "3 High-Yielding Dividend Stocks Near Their 52-Week Lows",
    "published": 1720872900,
    "day_prices": {},
    "sentiment": 0.9553186297416687
  },
  {
    "title": "Bristol Myers (BMY) Loses 20.5% YTD: Should You Retain or Fold?",
    "published": 1720798380,
    "day_prices": {
      "2024-07-12T13:30:00+00:00": 41.06999969482422,
      "2024-07-12T14:30:00+00:00": 40.689998626708984,
      "2024-07-12T15:30:00+00:00": 40.75,
      "2024-07-12T16:30:00+00:00": 40.459999084472656,
      "2024-07-12T17:30:00+00:00": 40.599998474121094,
      "2024-07-12T18:30:00+00:00": 40.73500061035156,
      "2024-07-12T19:30:00+00:00": 40.755001068115234
    },
    "sentiment": 0.5422225594520569
  },
  {
    "title": "Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates",
    "published": 1720732202,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 41.25,
      "2024-07-11T14:30:00+00:00": 41.290000915527344,
      "2024-07-11T15:30:00+00:00": 41.105499267578125,
      "2024-07-11T16:30:00+00:00": 41.06999969482422,
      "2024-07-11T17:30:00+00:00": 40.97999954223633,
      "2024-07-11T18:30:00+00:00": 40.997501373291016,
      "2024-07-11T19:30:00+00:00": 40.79999923706055
    },
    "sentiment": 0.9725209474563599
  },
  {
    "title": "Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%",
    "published": 1720689709,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 41.25,
      "2024-07-11T14:30:00+00:00": 41.290000915527344,
      "2024-07-11T15:30:00+00:00": 41.105499267578125,
      "2024-07-11T16:30:00+00:00": 41.06999969482422,
      "2024-07-11T17:30:00+00:00": 40.97999954223633,
      "2024-07-11T18:30:00+00:00": 40.997501373291016,
      "2024-07-11T19:30:00+00:00": 40.79999923706055
    },
    "sentiment": 0.8610618114471436
  },
  {
    "title": "3 Undervalued Stocks Ready for a Breakout This Summer",
    "published": 1720627200,
    "day_prices": {
      "2024-07-10T13:30:00+00:00": 40.869998931884766,
      "2024-07-10T14:30:00+00:00": 40.875,
      "2024-07-10T15:30:00+00:00": 40.874698638916016,
      "2024-07-10T16:30:00+00:00": 40.875,
      "2024-07-10T17:30:00+00:00": 40.85499954223633,
      "2024-07-10T18:30:00+00:00": 40.84000015258789,
      "2024-07-10T19:30:00+00:00": 41.0
    },
    "sentiment": 0.5584272146224976
  },
  {
    "title": "The 7 Best Warren Buffett Stocks to Buy in July 2024",
    "published": 1720525200,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 39.810001373291016,
      "2024-07-09T14:30:00+00:00": 40.28499984741211,
      "2024-07-09T15:30:00+00:00": 40.349998474121094,
      "2024-07-09T16:30:00+00:00": 40.547401428222656,
      "2024-07-09T17:30:00+00:00": 40.599998474121094,
      "2024-07-09T18:30:00+00:00": 40.52000045776367,
      "2024-07-09T19:30:00+00:00": 40.7400016784668
    },
    "sentiment": 0.930526614189148
  },
  {
    "title": "2seventy bio's Abecma: Compelling Investment In Multiple Myeloma Despite Competition",
    "published": 1720508785,
    "day_prices": {
      "2024-07-09T13:30:00+00:00": 39.810001373291016,
      "2024-07-09T14:30:00+00:00": 40.28499984741211,
      "2024-07-09T15:30:00+00:00": 40.349998474121094,
      "2024-07-09T16:30:00+00:00": 40.547401428222656,
      "2024-07-09T17:30:00+00:00": 40.599998474121094,
      "2024-07-09T18:30:00+00:00": 40.52000045776367,
      "2024-07-09T19:30:00+00:00": 40.7400016784668
    },
    "sentiment": 0.9448773860931396
  },
  {
    "title": "Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day",
    "published": 1720436340,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 39.63999938964844,
      "2024-07-08T14:30:00+00:00": 39.810001373291016,
      "2024-07-08T15:30:00+00:00": 39.665000915527344,
      "2024-07-08T16:30:00+00:00": 39.900001525878906,
      "2024-07-08T17:30:00+00:00": 39.93000030517578,
      "2024-07-08T18:30:00+00:00": 39.904998779296875,
      "2024-07-08T19:30:00+00:00": 39.87649917602539
    },
    "sentiment": 0.8646582365036011
  },
  {
    "title": "Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue?",
    "published": 1725031899,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 49.720001220703125,
      "2024-08-30T14:30:00+00:00": 50.04499816894531,
      "2024-08-30T15:30:00+00:00": 49.900001525878906,
      "2024-08-30T16:30:00+00:00": 50.0,
      "2024-08-30T17:30:00+00:00": 50.005001068115234,
      "2024-08-30T18:30:00+00:00": 50.01499938964844,
      "2024-08-30T19:30:00+00:00": 49.9900016784668
    },
    "sentiment": 0.9528279900550842
  },
  {
    "title": "Bristol-Myers Squibb (NYSE:BMY) investors are sitting on a loss of 17% if they invested three years ago",
    "published": 1724940014,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 49.27000045776367,
      "2024-08-29T14:30:00+00:00": 49.26499938964844,
      "2024-08-29T15:30:00+00:00": 49.369998931884766,
      "2024-08-29T16:30:00+00:00": 49.70000076293945,
      "2024-08-29T17:30:00+00:00": 49.5,
      "2024-08-29T18:30:00+00:00": 49.66999816894531,
      "2024-08-29T19:30:00+00:00": 49.70000076293945
    },
    "sentiment": 0.8573725819587708
  },
  {
    "title": "Piper ups Neurocrine to overweight, says '568 still in the game",
    "published": 1724924100,
    "day_prices": {
      "2024-08-29T13:30:00+00:00": 49.27000045776367,
      "2024-08-29T14:30:00+00:00": 49.26499938964844,
      "2024-08-29T15:30:00+00:00": 49.369998931884766,
      "2024-08-29T16:30:00+00:00": 49.70000076293945,
      "2024-08-29T17:30:00+00:00": 49.5,
      "2024-08-29T18:30:00+00:00": 49.66999816894531,
      "2024-08-29T19:30:00+00:00": 49.70000076293945
    },
    "sentiment": 0.8138301372528076
  },
  {
    "title": "Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday",
    "published": 1724883586,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 48.1150016784668,
      "2024-08-28T14:30:00+00:00": 49.41999816894531,
      "2024-08-28T15:30:00+00:00": 49.7400016784668,
      "2024-08-28T16:30:00+00:00": 49.29499816894531,
      "2024-08-28T17:30:00+00:00": 49.22999954223633,
      "2024-08-28T18:30:00+00:00": 49.03499984741211,
      "2024-08-28T19:30:00+00:00": 49.15999984741211
    },
    "sentiment": 0.7627997994422913
  },
  {
    "title": "3 High-Yield Dividend Stocks With Payout Ratios Below 75%",
    "published": 1724842800,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 48.1150016784668,
      "2024-08-28T14:30:00+00:00": 49.41999816894531,
      "2024-08-28T15:30:00+00:00": 49.7400016784668,
      "2024-08-28T16:30:00+00:00": 49.29499816894531,
      "2024-08-28T17:30:00+00:00": 49.22999954223633,
      "2024-08-28T18:30:00+00:00": 49.03499984741211,
      "2024-08-28T19:30:00+00:00": 49.15999984741211
    },
    "sentiment": 0.5823111534118652
  },
  {
    "title": "Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday",
    "published": 1724836800,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 48.1150016784668,
      "2024-08-28T14:30:00+00:00": 49.41999816894531,
      "2024-08-28T15:30:00+00:00": 49.7400016784668,
      "2024-08-28T16:30:00+00:00": 49.29499816894531,
      "2024-08-28T17:30:00+00:00": 49.22999954223633,
      "2024-08-28T18:30:00+00:00": 49.03499984741211,
      "2024-08-28T19:30:00+00:00": 49.15999984741211
    },
    "sentiment": 0.9430198669433594
  },
  {
    "title": "Bristol Myers price target raised by $2 at Jefferies, here's why",
    "published": 1724829060,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 48.1150016784668,
      "2024-08-28T14:30:00+00:00": 49.41999816894531,
      "2024-08-28T15:30:00+00:00": 49.7400016784668,
      "2024-08-28T16:30:00+00:00": 49.29499816894531,
      "2024-08-28T17:30:00+00:00": 49.22999954223633,
      "2024-08-28T18:30:00+00:00": 49.03499984741211,
      "2024-08-28T19:30:00+00:00": 49.15999984741211
    },
    "sentiment": 0.6274365186691284
  },
  {
    "title": "Neurocrine Plummets 19% \u2014 Does It Still Have A Shot At This 'Significant Market Opportunity?'",
    "published": 1724822915,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 48.1150016784668,
      "2024-08-28T14:30:00+00:00": 49.41999816894531,
      "2024-08-28T15:30:00+00:00": 49.7400016784668,
      "2024-08-28T16:30:00+00:00": 49.29499816894531,
      "2024-08-28T17:30:00+00:00": 49.22999954223633,
      "2024-08-28T18:30:00+00:00": 49.03499984741211,
      "2024-08-28T19:30:00+00:00": 49.15999984741211
    },
    "sentiment": 0.8523566722869873
  },
  {
    "title": "PureTech Health plc ? Half-Year Report",
    "published": 1724810460,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 48.1150016784668,
      "2024-08-28T14:30:00+00:00": 49.41999816894531,
      "2024-08-28T15:30:00+00:00": 49.7400016784668,
      "2024-08-28T16:30:00+00:00": 49.29499816894531,
      "2024-08-28T17:30:00+00:00": 49.22999954223633,
      "2024-08-28T18:30:00+00:00": 49.03499984741211,
      "2024-08-28T19:30:00+00:00": 49.15999984741211
    },
    "sentiment": 0.9154718518257141
  },
  {
    "title": "Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna",
    "published": 1724725500,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 48.36000061035156,
      "2024-08-27T14:30:00+00:00": 47.93000030517578,
      "2024-08-27T15:30:00+00:00": 47.85499954223633,
      "2024-08-27T16:30:00+00:00": 47.994998931884766,
      "2024-08-27T17:30:00+00:00": 48.039798736572266,
      "2024-08-27T18:30:00+00:00": 48.05500030517578,
      "2024-08-27T19:30:00+00:00": 48.10499954223633
    },
    "sentiment": 0.8037766814231873
  },
  {
    "title": "Bristol Myers: presentations planned at ESC congress",
    "published": 1724658494,
    "day_prices": {
      "2024-08-26T13:30:00+00:00": 48.16999816894531,
      "2024-08-26T14:30:00+00:00": 48.30500030517578,
      "2024-08-26T15:30:00+00:00": 48.029998779296875,
      "2024-08-26T16:30:00+00:00": 48.2400016784668,
      "2024-08-26T17:30:00+00:00": 48.22999954223633,
      "2024-08-26T18:30:00+00:00": 48.209999084472656,
      "2024-08-26T19:30:00+00:00": 48.314998626708984
    },
    "sentiment": 0.9478347897529602
  },
  {
    "title": "Merck, Bristol Myers cancer drugs included in September FDA advisory panel meeting",
    "published": 1724409000,
    "day_prices": {
      "2024-08-23T13:30:00+00:00": 47.66999816894531,
      "2024-08-23T14:30:00+00:00": 47.7599983215332,
      "2024-08-23T15:30:00+00:00": 48.19499969482422,
      "2024-08-23T16:30:00+00:00": 47.97999954223633,
      "2024-08-23T17:30:00+00:00": 48.0,
      "2024-08-23T18:30:00+00:00": 47.96500015258789,
      "2024-08-23T19:30:00+00:00": 48.1150016784668
    },
    "sentiment": 0.9249929189682007
  },
  {
    "title": "Bristol Myers Squibb : Statement on Oncologic Drugs Advisory Committee (ODAC) Meeting to Discuss PD-L1 Expression Levels in Gastric and Esophageal Cancers",
    "published": 1724339283,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 48.56999969482422,
      "2024-08-22T14:30:00+00:00": 47.405601501464844,
      "2024-08-22T15:30:00+00:00": 47.435001373291016,
      "2024-08-22T16:30:00+00:00": 47.242000579833984,
      "2024-08-22T17:30:00+00:00": 47.15999984741211,
      "2024-08-22T18:30:00+00:00": 47.494998931884766,
      "2024-08-22T19:30:00+00:00": 47.560001373291016
    },
    "sentiment": 0.9222673177719116
  },
  {
    "title": "Bristol Myers Squibb Breaks Below 200-Day Moving Average - Notable for BMY",
    "published": 1724326740,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 48.56999969482422,
      "2024-08-22T14:30:00+00:00": 47.405601501464844,
      "2024-08-22T15:30:00+00:00": 47.435001373291016,
      "2024-08-22T16:30:00+00:00": 47.242000579833984,
      "2024-08-22T17:30:00+00:00": 47.15999984741211,
      "2024-08-22T18:30:00+00:00": 47.494998931884766,
      "2024-08-22T19:30:00+00:00": 47.560001373291016
    },
    "sentiment": 0.6279208660125732
  },
  {
    "title": "FDA accepts BMS\u2019 sBLA for Opdivo-Yervoy combo for HCC",
    "published": 1724315543,
    "day_prices": {
      "2024-08-22T13:30:00+00:00": 48.56999969482422,
      "2024-08-22T14:30:00+00:00": 47.405601501464844,
      "2024-08-22T15:30:00+00:00": 47.435001373291016,
      "2024-08-22T16:30:00+00:00": 47.242000579833984,
      "2024-08-22T17:30:00+00:00": 47.15999984741211,
      "2024-08-22T18:30:00+00:00": 47.494998931884766,
      "2024-08-22T19:30:00+00:00": 47.560001373291016
    },
    "sentiment": 0.8009316325187683
  },
  {
    "title": "Bristol Myers: sBLA accepted by FDA in liver cancer",
    "published": 1724225716,
    "day_prices": {
      "2024-08-21T13:30:00+00:00": 48.779998779296875,
      "2024-08-21T14:30:00+00:00": 48.94499969482422,
      "2024-08-21T15:30:00+00:00": 48.869998931884766,
      "2024-08-21T16:30:00+00:00": 48.64500045776367,
      "2024-08-21T17:30:00+00:00": 48.47999954223633,
      "2024-08-21T18:30:00+00:00": 48.400001525878906,
      "2024-08-21T19:30:00+00:00": 48.255001068115234
    },
    "sentiment": 0.6901514530181885
  },
  {
    "title": "Franklin Managed Income Fund Q2 2024 Commentary",
    "published": 1724208900,
    "day_prices": {
      "2024-08-21T13:30:00+00:00": 48.779998779296875,
      "2024-08-21T14:30:00+00:00": 48.94499969482422,
      "2024-08-21T15:30:00+00:00": 48.869998931884766,
      "2024-08-21T16:30:00+00:00": 48.64500045776367,
      "2024-08-21T17:30:00+00:00": 48.47999954223633,
      "2024-08-21T18:30:00+00:00": 48.400001525878906,
      "2024-08-21T19:30:00+00:00": 48.255001068115234
    },
    "sentiment": 0.9407536387443542
  },
  {
    "title": "3 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade",
    "published": 1724143140,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 49.27000045776367,
      "2024-08-20T14:30:00+00:00": 49.23500061035156,
      "2024-08-20T15:30:00+00:00": 49.349998474121094,
      "2024-08-20T16:30:00+00:00": 49.19499969482422,
      "2024-08-20T17:30:00+00:00": 49.02000045776367,
      "2024-08-20T18:30:00+00:00": 49.13999938964844,
      "2024-08-20T19:30:00+00:00": 49.029998779296875
    },
    "sentiment": 0.9368075132369995
  },
  {
    "title": "European Medicines Agency Validates Bristol Myers Squibb\u2019s Application for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma",
    "published": 1724065140,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 49.380001068115234,
      "2024-08-19T14:30:00+00:00": 49.68000030517578,
      "2024-08-19T15:30:00+00:00": 49.89500045776367,
      "2024-08-19T16:30:00+00:00": 49.779998779296875,
      "2024-08-19T17:30:00+00:00": 49.77000045776367,
      "2024-08-19T18:30:00+00:00": 49.345001220703125,
      "2024-08-19T19:30:00+00:00": 49.435001373291016
    },
    "sentiment": 0.8585729598999023
  },
  {
    "title": "Bristol Myers Gets European Review of Expanded Breyanzi Use",
    "published": 1724053272,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 49.380001068115234,
      "2024-08-19T14:30:00+00:00": 49.68000030517578,
      "2024-08-19T15:30:00+00:00": 49.89500045776367,
      "2024-08-19T16:30:00+00:00": 49.779998779296875,
      "2024-08-19T17:30:00+00:00": 49.77000045776367,
      "2024-08-19T18:30:00+00:00": 49.345001220703125,
      "2024-08-19T19:30:00+00:00": 49.435001373291016
    },
    "sentiment": 0.8014196157455444
  },
  {
    "title": "Neurocrine price target raised by $12 at Jefferies, here's why",
    "published": 1724051580,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 49.380001068115234,
      "2024-08-19T14:30:00+00:00": 49.68000030517578,
      "2024-08-19T15:30:00+00:00": 49.89500045776367,
      "2024-08-19T16:30:00+00:00": 49.779998779296875,
      "2024-08-19T17:30:00+00:00": 49.77000045776367,
      "2024-08-19T18:30:00+00:00": 49.345001220703125,
      "2024-08-19T19:30:00+00:00": 49.435001373291016
    },
    "sentiment": 0.7755223512649536
  },
  {
    "title": "Bristol Myers announces EMA validation to expand Brevanzi indication",
    "published": 1724047320,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 49.380001068115234,
      "2024-08-19T14:30:00+00:00": 49.68000030517578,
      "2024-08-19T15:30:00+00:00": 49.89500045776367,
      "2024-08-19T16:30:00+00:00": 49.779998779296875,
      "2024-08-19T17:30:00+00:00": 49.77000045776367,
      "2024-08-19T18:30:00+00:00": 49.345001220703125,
      "2024-08-19T19:30:00+00:00": 49.435001373291016
    },
    "sentiment": 0.785480260848999
  },
  {
    "title": "Where Will Bristol Myers Squibb Be in 5 Years?",
    "published": 1723987440,
    "day_prices": {},
    "sentiment": 0.9230971932411194
  },
  {
    "title": "Bristol-Myers Squibb Insider Lowered Holding By 39% During Last Year",
    "published": 1723813215,
    "day_prices": {
      "2024-08-16T13:30:00+00:00": 49.11000061035156,
      "2024-08-16T14:30:00+00:00": 49.220001220703125,
      "2024-08-16T15:30:00+00:00": 49.584999084472656,
      "2024-08-16T16:30:00+00:00": 49.185001373291016,
      "2024-08-16T17:30:00+00:00": 49.4900016784668,
      "2024-08-16T18:30:00+00:00": 49.54499816894531,
      "2024-08-16T19:30:00+00:00": 49.5
    },
    "sentiment": 0.937901496887207
  },
  {
    "title": "The Feds Are \u2018Playing Nice\u2019 With Pharma, At Least for Now",
    "published": 1723807800,
    "day_prices": {
      "2024-08-16T13:30:00+00:00": 49.11000061035156,
      "2024-08-16T14:30:00+00:00": 49.220001220703125,
      "2024-08-16T15:30:00+00:00": 49.584999084472656,
      "2024-08-16T16:30:00+00:00": 49.185001373291016,
      "2024-08-16T17:30:00+00:00": 49.4900016784668,
      "2024-08-16T18:30:00+00:00": 49.54499816894531,
      "2024-08-16T19:30:00+00:00": 49.5
    },
    "sentiment": 0.7242122292518616
  },
  {
    "title": "US Government Sets Out Prices of 10 Drugs in Medicare Negotiations",
    "published": 1723749378,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.9146358370780945
  },
  {
    "title": "All You Need to Know About Bristol Myers (BMY) Rating Upgrade to Buy",
    "published": 1723737632,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.9201846718788147
  },
  {
    "title": "Big Pharma: The government revealed its list of negotiated drug prices. Here are the reactions.",
    "published": 1723733344,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.9261020421981812
  },
  {
    "title": "Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock",
    "published": 1723726816,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.9245907068252563
  },
  {
    "title": "Medicare-negotiated prices 'benign' for Bristol Myers, says Barclays",
    "published": 1723718880,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.5338683724403381
  },
  {
    "title": "AMR Update - Mid-2024",
    "published": 1723715256,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.9433442950248718
  },
  {
    "title": "Bristol Myers, Novartis react as Medicare prices for key drugs announced",
    "published": 1723713720,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.3734457194805145
  },
  {
    "title": "Biden administration announces lower prices for 10 Medicare drugs in 2026",
    "published": 1723705200,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.9018750786781311
  },
  {
    "title": "U.S. government targets $6B in savings from first Medicare drug price negotiations",
    "published": 1723703700,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.9052250981330872
  },
  {
    "title": "Abata Therapeutics announces equity investment from Bristol Myers",
    "published": 1723702500,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 49.29999923706055,
      "2024-08-15T14:30:00+00:00": 49.02000045776367,
      "2024-08-15T15:30:00+00:00": 49.06999969482422,
      "2024-08-15T16:30:00+00:00": 48.974998474121094,
      "2024-08-15T17:30:00+00:00": 48.630001068115234,
      "2024-08-15T18:30:00+00:00": 48.755001068115234,
      "2024-08-15T19:30:00+00:00": 49.0
    },
    "sentiment": 0.8118454217910767
  },
  {
    "title": "A Market Washout Can\u2019t Stop Musk From Innovating\u2026 or Us From Profiting",
    "published": 1723668066,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 49.060001373291016,
      "2024-08-14T14:30:00+00:00": 48.52000045776367,
      "2024-08-14T15:30:00+00:00": 48.52000045776367,
      "2024-08-14T16:30:00+00:00": 48.33000183105469,
      "2024-08-14T17:30:00+00:00": 48.310001373291016,
      "2024-08-14T18:30:00+00:00": 48.459999084472656,
      "2024-08-14T19:30:00+00:00": 48.470001220703125
    },
    "sentiment": 0.6957862973213196
  },
  {
    "title": "Pharma ETFs in Focus Post Solid Q2 Earnings",
    "published": 1723650540,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 49.060001373291016,
      "2024-08-14T14:30:00+00:00": 48.52000045776367,
      "2024-08-14T15:30:00+00:00": 48.52000045776367,
      "2024-08-14T16:30:00+00:00": 48.33000183105469,
      "2024-08-14T17:30:00+00:00": 48.310001373291016,
      "2024-08-14T18:30:00+00:00": 48.459999084472656,
      "2024-08-14T19:30:00+00:00": 48.470001220703125
    },
    "sentiment": 0.9467887282371521
  },
  {
    "title": "Invesco Growth And Income Fund Q2 2024 Review",
    "published": 1723629300,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 49.060001373291016,
      "2024-08-14T14:30:00+00:00": 48.52000045776367,
      "2024-08-14T15:30:00+00:00": 48.52000045776367,
      "2024-08-14T16:30:00+00:00": 48.33000183105469,
      "2024-08-14T17:30:00+00:00": 48.310001373291016,
      "2024-08-14T18:30:00+00:00": 48.459999084472656,
      "2024-08-14T19:30:00+00:00": 48.470001220703125
    },
    "sentiment": 0.9436347484588623
  },
  {
    "title": "Prothena price target lowered by $4 at Oppenheimer, here's why",
    "published": 1723617900,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 49.060001373291016,
      "2024-08-14T14:30:00+00:00": 48.52000045776367,
      "2024-08-14T15:30:00+00:00": 48.52000045776367,
      "2024-08-14T16:30:00+00:00": 48.33000183105469,
      "2024-08-14T17:30:00+00:00": 48.310001373291016,
      "2024-08-14T18:30:00+00:00": 48.459999084472656,
      "2024-08-14T19:30:00+00:00": 48.470001220703125
    },
    "sentiment": 0.8296473026275635
  },
  {
    "title": "IN BRIEF: Evotec claims \"strong progress\" in Bristol Myers team-up",
    "published": 1723530960,
    "day_prices": {
      "2024-08-13T13:30:00+00:00": 47.47999954223633,
      "2024-08-13T14:30:00+00:00": 47.970001220703125,
      "2024-08-13T15:30:00+00:00": 48.44499969482422,
      "2024-08-13T16:30:00+00:00": 48.564998626708984,
      "2024-08-13T17:30:00+00:00": 48.834999084472656,
      "2024-08-13T18:30:00+00:00": 48.56999969482422,
      "2024-08-13T19:30:00+00:00": 49.038299560546875
    },
    "sentiment": 0.9458807706832886
  },
  {
    "title": "Bristol Myers (BMY) Gains 16% in a Month: Should You Buy or Wait?",
    "published": 1723481040,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 46.77000045776367,
      "2024-08-12T14:30:00+00:00": 47.20500183105469,
      "2024-08-12T15:30:00+00:00": 47.0,
      "2024-08-12T16:30:00+00:00": 46.959999084472656,
      "2024-08-12T17:30:00+00:00": 46.78499984741211,
      "2024-08-12T18:30:00+00:00": 46.685001373291016,
      "2024-08-12T19:30:00+00:00": 46.95500183105469
    },
    "sentiment": 0.8635689616203308
  },
  {
    "title": "Bristol Myers price target raised by $8 at TD Cowen, here's why",
    "published": 1723444440,
    "day_prices": {
      "2024-08-12T13:30:00+00:00": 46.77000045776367,
      "2024-08-12T14:30:00+00:00": 47.20500183105469,
      "2024-08-12T15:30:00+00:00": 47.0,
      "2024-08-12T16:30:00+00:00": 46.959999084472656,
      "2024-08-12T17:30:00+00:00": 46.78499984741211,
      "2024-08-12T18:30:00+00:00": 46.685001373291016,
      "2024-08-12T19:30:00+00:00": 46.95500183105469
    },
    "sentiment": 0.7418271899223328
  },
  {
    "title": "Bristol-Myers Squibb Co: Is It A Buy?",
    "published": 1723380600,
    "day_prices": {},
    "sentiment": 0.9195252060890198
  },
  {
    "title": "Bristol-Myers Squibb Company's (NYSE:BMY) recent 4.2% pullback adds to one-year year losses, institutional owners may take drastic measures",
    "published": 1723294813,
    "day_prices": {},
    "sentiment": 0.9540884494781494
  },
  {
    "title": "Smart Money Is Betting Big In BMY Options",
    "published": 1723206900,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 46.84000015258789,
      "2024-08-09T14:30:00+00:00": 47.165000915527344,
      "2024-08-09T15:30:00+00:00": 47.064998626708984,
      "2024-08-09T16:30:00+00:00": 46.970001220703125,
      "2024-08-09T17:30:00+00:00": 47.01499938964844,
      "2024-08-09T18:30:00+00:00": 46.79499816894531,
      "2024-08-09T19:30:00+00:00": 46.79499816894531
    },
    "sentiment": 0.8071572184562683
  },
  {
    "title": "Big Pharma Cuts R&D, Sending Shudders Through Industry",
    "published": 1723113000,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 46.56999969482422,
      "2024-08-08T14:30:00+00:00": 46.91999816894531,
      "2024-08-08T15:30:00+00:00": 46.650001525878906,
      "2024-08-08T16:30:00+00:00": 46.55500030517578,
      "2024-08-08T17:30:00+00:00": 46.560001373291016,
      "2024-08-08T18:30:00+00:00": 46.61000061035156,
      "2024-08-08T19:30:00+00:00": 46.689998626708984
    },
    "sentiment": 0.9528546929359436
  },
  {
    "title": "Bristol Myers Stock (NYSE:BMY): Perfect Place to Wait Out Market Volatility",
    "published": 1723088400,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 46.56999969482422,
      "2024-08-08T14:30:00+00:00": 46.91999816894531,
      "2024-08-08T15:30:00+00:00": 46.650001525878906,
      "2024-08-08T16:30:00+00:00": 46.55500030517578,
      "2024-08-08T17:30:00+00:00": 46.560001373291016,
      "2024-08-08T18:30:00+00:00": 46.61000061035156,
      "2024-08-08T19:30:00+00:00": 46.689998626708984
    },
    "sentiment": 0.9126921892166138
  },
  {
    "title": "Bloomsbury Grants Shares to Executives on Performance Basis",
    "published": 1723032000,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 47.43000030517578,
      "2024-08-07T14:30:00+00:00": 47.88999938964844,
      "2024-08-07T15:30:00+00:00": 47.51499938964844,
      "2024-08-07T16:30:00+00:00": 47.474998474121094,
      "2024-08-07T17:30:00+00:00": 47.275001525878906,
      "2024-08-07T18:30:00+00:00": 46.8849983215332,
      "2024-08-07T19:30:00+00:00": 46.73500061035156
    },
    "sentiment": 0.9469819068908691
  },
  {
    "title": "Fidelity Freedom 2015 Fund Q2 2024 Review",
    "published": 1723018500,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 47.43000030517578,
      "2024-08-07T14:30:00+00:00": 47.88999938964844,
      "2024-08-07T15:30:00+00:00": 47.51499938964844,
      "2024-08-07T16:30:00+00:00": 47.474998474121094,
      "2024-08-07T17:30:00+00:00": 47.275001525878906,
      "2024-08-07T18:30:00+00:00": 46.8849983215332,
      "2024-08-07T19:30:00+00:00": 46.73500061035156
    },
    "sentiment": 0.9472967386245728
  },
  {
    "title": "Bristol-Myers Squibb: Sell Now, Buy Later (Rating Downgrade)",
    "published": 1722975632,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 47.88999938964844,
      "2024-08-06T14:30:00+00:00": 47.69839859008789,
      "2024-08-06T15:30:00+00:00": 47.43349838256836,
      "2024-08-06T16:30:00+00:00": 47.439998626708984,
      "2024-08-06T17:30:00+00:00": 47.61000061035156,
      "2024-08-06T18:30:00+00:00": 47.5099983215332,
      "2024-08-06T19:30:00+00:00": 47.45000076293945
    },
    "sentiment": 0.8552334904670715
  },
  {
    "title": "The Prognosis For Perspective Therapeutics",
    "published": 1722888560,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 47.880001068115234,
      "2024-08-05T14:30:00+00:00": 48.02000045776367,
      "2024-08-05T15:30:00+00:00": 47.650001525878906,
      "2024-08-05T16:30:00+00:00": 47.63999938964844,
      "2024-08-05T17:30:00+00:00": 47.86000061035156,
      "2024-08-05T18:30:00+00:00": 47.78499984741211,
      "2024-08-05T19:30:00+00:00": 47.44499969482422
    },
    "sentiment": 0.9339421987533569
  },
  {
    "title": "Pfizer: Tracking Well Above The Industry",
    "published": 1722857131,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 47.880001068115234,
      "2024-08-05T14:30:00+00:00": 48.02000045776367,
      "2024-08-05T15:30:00+00:00": 47.650001525878906,
      "2024-08-05T16:30:00+00:00": 47.63999938964844,
      "2024-08-05T17:30:00+00:00": 47.86000061035156,
      "2024-08-05T18:30:00+00:00": 47.78499984741211,
      "2024-08-05T19:30:00+00:00": 47.44499969482422
    },
    "sentiment": 0.8902126550674438
  },
  {
    "title": "Bristol Myers Squibb (BMY) Crossed Above the 200-Day Moving Average: What That Means for Investors",
    "published": 1722605404,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 49.119998931884766,
      "2024-08-02T14:30:00+00:00": 49.02000045776367,
      "2024-08-02T15:30:00+00:00": 48.720001220703125,
      "2024-08-02T16:30:00+00:00": 48.77000045776367,
      "2024-08-02T17:30:00+00:00": 49.040000915527344,
      "2024-08-02T18:30:00+00:00": 49.01499938964844,
      "2024-08-02T19:30:00+00:00": 48.834999084472656
    },
    "sentiment": 0.5008119344711304
  },
  {
    "title": "Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore",
    "published": 1722520800,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 47.79999923706055,
      "2024-08-01T14:30:00+00:00": 47.52000045776367,
      "2024-08-01T15:30:00+00:00": 48.0,
      "2024-08-01T16:30:00+00:00": 48.084999084472656,
      "2024-08-01T17:30:00+00:00": 48.11000061035156,
      "2024-08-01T18:30:00+00:00": 48.448699951171875,
      "2024-08-01T19:30:00+00:00": 48.21500015258789
    },
    "sentiment": 0.9074241518974304
  },
  {
    "title": "BMY September 13th Options Begin Trading",
    "published": 1722484200,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 47.79999923706055,
      "2024-08-01T14:30:00+00:00": 47.52000045776367,
      "2024-08-01T15:30:00+00:00": 48.0,
      "2024-08-01T16:30:00+00:00": 48.084999084472656,
      "2024-08-01T17:30:00+00:00": 48.11000061035156,
      "2024-08-01T18:30:00+00:00": 48.448699951171875,
      "2024-08-01T19:30:00+00:00": 48.21500015258789
    },
    "sentiment": 0.9378249645233154
  }
]